User login
Why It's Hard for Healthcare Providers to Say I'm Sorry
It’s 1982, and in middle-school gyms across the country, among punch bowls and parental scrutiny, young girls and boys are slow-dancing with outstretched arms to a breathtaking song by the band Chicago. The song tells of the agonizing difficulty of apology, how despite the want and need to apologize, it is just too arduous.
Fast-forward 30 years, and it is hard to believe that cheesy No. 1 Billboard hit espoused the feelings that continue to haunt healthcare providers across the country: It’s hard for me to say I’m sorry.
Others Say It
If you look at the world around us, you see apology everywhere. Customer service representatives and customer-minded industries routinely let those words flow off their tongues with ease and grace.
While I was driving down the interstate last week, the number of traffic lanes shrunk from three to two to one. Anticipating widespread aggravation from weary travelers, the state transportation department deployed several large road signs every few miles; they read “WE APOLOGIZE FOR THE INCONVENIENCE … BEAR WITH US WHILE WE MAKE YOUR ROADS SMOOTHER AND SAFER.” Those simple messages made me feel like the congestion was not a senseless waste of time, that the state’s Department of Transportation was actually being strategic and thoughtful in their rationing of lanes during rush hour in the middle of the week.
Phone-based, customer-service departments figured out the simple apology a long time ago. While holding the line for a Lands’ End customer-service representative a few weeks ago, I heard, “We apologize for the delay. Your business is important to us. Please hold the line while we address callers ahead of you.” It validated for me that those phone representatives are not just sitting around eating lunch, completely ignoring my call, and that maybe there are others who procrastinated buying back-to-school backpacks until September—and just happened to call right before me.
I even got an apology at the dry cleaner. Amidst my last batch of clothes, my astute dry cleaner apparently found a very stubborn stain, which resisted all of their usual concoctions. It was on the back of a shirt and I probably would not have even noticed it was there. But nonetheless, they sent an apology tag, with a picture of a distraught butler who seemed to have struggled with that stain for hours.
Why Not Us?
So why is “sorry” so hard in healthcare? When things happen to patients, things that are inconvenient or downright dangerous, we have great difficulty in simply saying: “Hey, I am really sorry this happened to you,” or “I am so sorry you are still here. You must be really frustrated by our inefficiencies.”
I have the distinct pleasure of overseeing my hospital’s risk-management department for a few months. This means I get to see and hear what does and doesn’t happen to patients, which, at times, is misaligned with what should or shouldn’t happen to patients. When unanticipated events occur, the group launches into an investigation of what happened, why it happened, and the risk that it could happen again. After the initial dust settles and the facts are relayed from the care team to the risk-management team, the risk team always asks of those involved: “So what does the patient and their family know?” And we get a range of answers—some polished, some fumbled, some baffled.
The next question is: “Well, what should they know?” And that is always an easy question to answer. They should know the truth. Not just some of the truth, or half the truth, or a partial truth. Not what the care team thinks the patient “can handle.” They should just get the truth. To the best of the team’s ability, they should tell the patient:
- What (they think) happened;
- Why (they think) it happened;
- What it means for the patient; and
- What they are going to do to make it not happen again.
And then the patient (and family members) deserve an apology—sincere, compassionate, genuine. The apology should be the easy part, as most providers do not always know what happened, why it happened, or what they are going to do to prevent it from happening, but they usually truly do feel sorry that it happened at all.
“Sorry”=Positive Results
Patients are unanimous in their desire to be informed if a medical error has occurred; focus groups have found that patients believe such information would enhance their trust in their physicians and would reassure them that they were receiving complete information. And they want an apology.1
But interestingly, many physicians believe that full disclosure with apology is not warranted or appropriate, and that the apology could erode patient trust, might scare the patient, and might increase the risk of legal liability.1
There is little evidence that disclosure is harmful or detrimental, and there is some evidence that it is beneficial to the medical industry (i.e. reduces claims and litigation costs). A study published in 2010 from the University of Michigan Health System found a disclosure-with-compensation program was associated with a 36% reduction in new claims, a 65% reduction in lawsuits, and a 59% reduction in total liability cost.2
I have witnessed this phenomenon from both sides. My mother, who has Alzheimer’s and lives in an assisted-living facility, recently was given twice the dose of her medications one morning. She was “given” her night medications by being placed in her room, which she has no recollection of (the staff are supposed to watch her take her medications). The next morning, she saw the medications and took them, then took another dose when the nurse came by to give her morning medications. It was not realized until she’d already taken the medications and the staff noticed the medicine cup from the night before. My mom said she felt a little weak and dizzy for a few hours, but nothing significant, and she fully recovered. Interestingly, my mom mentioned it in passing, but no one called to let us know a medication error had occurred. Although she was not harmed, it made us, her family, lose a little trust in the facility because we found out about it indirectly, without any acknowledgement or apology.
On the other side of the equation, I have witnessed countless numbers of patient events in which providers feel worried and uncomfortable about the effects of disclosure with apology on themselves and their patients.
The bottom line is, disclosure with apology is needed and appreciated by patients, and it is absolutely the right thing to do. So download that cheesy Chicago song to your iPod and practice saying (or singing) “I’m sorry.” If the butler with chemicals can do it, so can we.
Dr. Scheurer is a hospitalist and chief quality officer at the Medical University of South Carolina in Charleston. She is physician editor of The Hospitalist. Email her at [email protected].
References
- Gallagher TH, Waterman AD, Ebers AG, Fraser VJ, Levinson W. Patients’ and physicians’ attitudes regarding the disclosure of medical errors. JAMA. 2003;289(8):1001-1007.
- Kachalia A, Kaufman SR, Boothman R, et al. Liability claims and costs before and after implementation of a medical error disclosure program. Ann Intern Med. 2010;153(4):213-221.
It’s 1982, and in middle-school gyms across the country, among punch bowls and parental scrutiny, young girls and boys are slow-dancing with outstretched arms to a breathtaking song by the band Chicago. The song tells of the agonizing difficulty of apology, how despite the want and need to apologize, it is just too arduous.
Fast-forward 30 years, and it is hard to believe that cheesy No. 1 Billboard hit espoused the feelings that continue to haunt healthcare providers across the country: It’s hard for me to say I’m sorry.
Others Say It
If you look at the world around us, you see apology everywhere. Customer service representatives and customer-minded industries routinely let those words flow off their tongues with ease and grace.
While I was driving down the interstate last week, the number of traffic lanes shrunk from three to two to one. Anticipating widespread aggravation from weary travelers, the state transportation department deployed several large road signs every few miles; they read “WE APOLOGIZE FOR THE INCONVENIENCE … BEAR WITH US WHILE WE MAKE YOUR ROADS SMOOTHER AND SAFER.” Those simple messages made me feel like the congestion was not a senseless waste of time, that the state’s Department of Transportation was actually being strategic and thoughtful in their rationing of lanes during rush hour in the middle of the week.
Phone-based, customer-service departments figured out the simple apology a long time ago. While holding the line for a Lands’ End customer-service representative a few weeks ago, I heard, “We apologize for the delay. Your business is important to us. Please hold the line while we address callers ahead of you.” It validated for me that those phone representatives are not just sitting around eating lunch, completely ignoring my call, and that maybe there are others who procrastinated buying back-to-school backpacks until September—and just happened to call right before me.
I even got an apology at the dry cleaner. Amidst my last batch of clothes, my astute dry cleaner apparently found a very stubborn stain, which resisted all of their usual concoctions. It was on the back of a shirt and I probably would not have even noticed it was there. But nonetheless, they sent an apology tag, with a picture of a distraught butler who seemed to have struggled with that stain for hours.
Why Not Us?
So why is “sorry” so hard in healthcare? When things happen to patients, things that are inconvenient or downright dangerous, we have great difficulty in simply saying: “Hey, I am really sorry this happened to you,” or “I am so sorry you are still here. You must be really frustrated by our inefficiencies.”
I have the distinct pleasure of overseeing my hospital’s risk-management department for a few months. This means I get to see and hear what does and doesn’t happen to patients, which, at times, is misaligned with what should or shouldn’t happen to patients. When unanticipated events occur, the group launches into an investigation of what happened, why it happened, and the risk that it could happen again. After the initial dust settles and the facts are relayed from the care team to the risk-management team, the risk team always asks of those involved: “So what does the patient and their family know?” And we get a range of answers—some polished, some fumbled, some baffled.
The next question is: “Well, what should they know?” And that is always an easy question to answer. They should know the truth. Not just some of the truth, or half the truth, or a partial truth. Not what the care team thinks the patient “can handle.” They should just get the truth. To the best of the team’s ability, they should tell the patient:
- What (they think) happened;
- Why (they think) it happened;
- What it means for the patient; and
- What they are going to do to make it not happen again.
And then the patient (and family members) deserve an apology—sincere, compassionate, genuine. The apology should be the easy part, as most providers do not always know what happened, why it happened, or what they are going to do to prevent it from happening, but they usually truly do feel sorry that it happened at all.
“Sorry”=Positive Results
Patients are unanimous in their desire to be informed if a medical error has occurred; focus groups have found that patients believe such information would enhance their trust in their physicians and would reassure them that they were receiving complete information. And they want an apology.1
But interestingly, many physicians believe that full disclosure with apology is not warranted or appropriate, and that the apology could erode patient trust, might scare the patient, and might increase the risk of legal liability.1
There is little evidence that disclosure is harmful or detrimental, and there is some evidence that it is beneficial to the medical industry (i.e. reduces claims and litigation costs). A study published in 2010 from the University of Michigan Health System found a disclosure-with-compensation program was associated with a 36% reduction in new claims, a 65% reduction in lawsuits, and a 59% reduction in total liability cost.2
I have witnessed this phenomenon from both sides. My mother, who has Alzheimer’s and lives in an assisted-living facility, recently was given twice the dose of her medications one morning. She was “given” her night medications by being placed in her room, which she has no recollection of (the staff are supposed to watch her take her medications). The next morning, she saw the medications and took them, then took another dose when the nurse came by to give her morning medications. It was not realized until she’d already taken the medications and the staff noticed the medicine cup from the night before. My mom said she felt a little weak and dizzy for a few hours, but nothing significant, and she fully recovered. Interestingly, my mom mentioned it in passing, but no one called to let us know a medication error had occurred. Although she was not harmed, it made us, her family, lose a little trust in the facility because we found out about it indirectly, without any acknowledgement or apology.
On the other side of the equation, I have witnessed countless numbers of patient events in which providers feel worried and uncomfortable about the effects of disclosure with apology on themselves and their patients.
The bottom line is, disclosure with apology is needed and appreciated by patients, and it is absolutely the right thing to do. So download that cheesy Chicago song to your iPod and practice saying (or singing) “I’m sorry.” If the butler with chemicals can do it, so can we.
Dr. Scheurer is a hospitalist and chief quality officer at the Medical University of South Carolina in Charleston. She is physician editor of The Hospitalist. Email her at [email protected].
References
- Gallagher TH, Waterman AD, Ebers AG, Fraser VJ, Levinson W. Patients’ and physicians’ attitudes regarding the disclosure of medical errors. JAMA. 2003;289(8):1001-1007.
- Kachalia A, Kaufman SR, Boothman R, et al. Liability claims and costs before and after implementation of a medical error disclosure program. Ann Intern Med. 2010;153(4):213-221.
It’s 1982, and in middle-school gyms across the country, among punch bowls and parental scrutiny, young girls and boys are slow-dancing with outstretched arms to a breathtaking song by the band Chicago. The song tells of the agonizing difficulty of apology, how despite the want and need to apologize, it is just too arduous.
Fast-forward 30 years, and it is hard to believe that cheesy No. 1 Billboard hit espoused the feelings that continue to haunt healthcare providers across the country: It’s hard for me to say I’m sorry.
Others Say It
If you look at the world around us, you see apology everywhere. Customer service representatives and customer-minded industries routinely let those words flow off their tongues with ease and grace.
While I was driving down the interstate last week, the number of traffic lanes shrunk from three to two to one. Anticipating widespread aggravation from weary travelers, the state transportation department deployed several large road signs every few miles; they read “WE APOLOGIZE FOR THE INCONVENIENCE … BEAR WITH US WHILE WE MAKE YOUR ROADS SMOOTHER AND SAFER.” Those simple messages made me feel like the congestion was not a senseless waste of time, that the state’s Department of Transportation was actually being strategic and thoughtful in their rationing of lanes during rush hour in the middle of the week.
Phone-based, customer-service departments figured out the simple apology a long time ago. While holding the line for a Lands’ End customer-service representative a few weeks ago, I heard, “We apologize for the delay. Your business is important to us. Please hold the line while we address callers ahead of you.” It validated for me that those phone representatives are not just sitting around eating lunch, completely ignoring my call, and that maybe there are others who procrastinated buying back-to-school backpacks until September—and just happened to call right before me.
I even got an apology at the dry cleaner. Amidst my last batch of clothes, my astute dry cleaner apparently found a very stubborn stain, which resisted all of their usual concoctions. It was on the back of a shirt and I probably would not have even noticed it was there. But nonetheless, they sent an apology tag, with a picture of a distraught butler who seemed to have struggled with that stain for hours.
Why Not Us?
So why is “sorry” so hard in healthcare? When things happen to patients, things that are inconvenient or downright dangerous, we have great difficulty in simply saying: “Hey, I am really sorry this happened to you,” or “I am so sorry you are still here. You must be really frustrated by our inefficiencies.”
I have the distinct pleasure of overseeing my hospital’s risk-management department for a few months. This means I get to see and hear what does and doesn’t happen to patients, which, at times, is misaligned with what should or shouldn’t happen to patients. When unanticipated events occur, the group launches into an investigation of what happened, why it happened, and the risk that it could happen again. After the initial dust settles and the facts are relayed from the care team to the risk-management team, the risk team always asks of those involved: “So what does the patient and their family know?” And we get a range of answers—some polished, some fumbled, some baffled.
The next question is: “Well, what should they know?” And that is always an easy question to answer. They should know the truth. Not just some of the truth, or half the truth, or a partial truth. Not what the care team thinks the patient “can handle.” They should just get the truth. To the best of the team’s ability, they should tell the patient:
- What (they think) happened;
- Why (they think) it happened;
- What it means for the patient; and
- What they are going to do to make it not happen again.
And then the patient (and family members) deserve an apology—sincere, compassionate, genuine. The apology should be the easy part, as most providers do not always know what happened, why it happened, or what they are going to do to prevent it from happening, but they usually truly do feel sorry that it happened at all.
“Sorry”=Positive Results
Patients are unanimous in their desire to be informed if a medical error has occurred; focus groups have found that patients believe such information would enhance their trust in their physicians and would reassure them that they were receiving complete information. And they want an apology.1
But interestingly, many physicians believe that full disclosure with apology is not warranted or appropriate, and that the apology could erode patient trust, might scare the patient, and might increase the risk of legal liability.1
There is little evidence that disclosure is harmful or detrimental, and there is some evidence that it is beneficial to the medical industry (i.e. reduces claims and litigation costs). A study published in 2010 from the University of Michigan Health System found a disclosure-with-compensation program was associated with a 36% reduction in new claims, a 65% reduction in lawsuits, and a 59% reduction in total liability cost.2
I have witnessed this phenomenon from both sides. My mother, who has Alzheimer’s and lives in an assisted-living facility, recently was given twice the dose of her medications one morning. She was “given” her night medications by being placed in her room, which she has no recollection of (the staff are supposed to watch her take her medications). The next morning, she saw the medications and took them, then took another dose when the nurse came by to give her morning medications. It was not realized until she’d already taken the medications and the staff noticed the medicine cup from the night before. My mom said she felt a little weak and dizzy for a few hours, but nothing significant, and she fully recovered. Interestingly, my mom mentioned it in passing, but no one called to let us know a medication error had occurred. Although she was not harmed, it made us, her family, lose a little trust in the facility because we found out about it indirectly, without any acknowledgement or apology.
On the other side of the equation, I have witnessed countless numbers of patient events in which providers feel worried and uncomfortable about the effects of disclosure with apology on themselves and their patients.
The bottom line is, disclosure with apology is needed and appreciated by patients, and it is absolutely the right thing to do. So download that cheesy Chicago song to your iPod and practice saying (or singing) “I’m sorry.” If the butler with chemicals can do it, so can we.
Dr. Scheurer is a hospitalist and chief quality officer at the Medical University of South Carolina in Charleston. She is physician editor of The Hospitalist. Email her at [email protected].
References
- Gallagher TH, Waterman AD, Ebers AG, Fraser VJ, Levinson W. Patients’ and physicians’ attitudes regarding the disclosure of medical errors. JAMA. 2003;289(8):1001-1007.
- Kachalia A, Kaufman SR, Boothman R, et al. Liability claims and costs before and after implementation of a medical error disclosure program. Ann Intern Med. 2010;153(4):213-221.
Why It's Hard for Healthcare Providers to Say I'm Sorry
Enter text here
Enter text here
Enter text here
Excessive Dosing, Inadequate Monitoring Blamed in Death
Excessive Dosing, Inadequate Monitoring Blamed in Death
A 39-year-old man with a history of pain complaints went to a Virginia hospital emergency department (ED) with a migraine. The defendant attending physician ordered IV medications; however, after several unsuccessful attempts to establish an IV line, the treating nurse administered 8 mg hydromorphone intramuscularly (IM). The patient was given a second dose of hydromorphone (6 mg IM) about an hour later before being transferred to a nonemergent room; there, he fell asleep. Loud snoring was noted, but the nurse responsible for monitoring the patient was not alarmed.
The patient then experienced respiratory arrest. Attempts to resuscitate him were unsuccessful.
Plaintiff for the decedent alleged negligence in improperly monitoring him and in failing to recognize signs of distress in a timely fashion. The plaintiff also claimed that the second dose overmedicated the decedent, leading to respiratory arrest. The plaintiff alleged negligence by the attending physician for ordering the second dose of hydromorphone and for transferring the decedent from the ED to a nonemergent room.
The claims against the defendant attending physician went to trial. The defendant claimed that the decedent was stable and showed no signs of acute distress at the time of transfer.
OUTCOME
The hospital settled for a confidential amount prior to trial. According to a published account, a defense verdict was returned in the trial against the attending physician.
COMMENT
This patient was given hydromorphone 8 mg IM at 5:55 am and hydromorphone 6 mg IM at 7:11 am as first-line treatment for migraine. He was discharged from the ED 10 minutes after receiving the second dose and transported to a gastroenterology suite for a previously scheduled colonoscopy. There, he was sparsely monitored, became apneic, and died.
Was the standard of care breached in this case?
The patient appears to have been offered a high-dose narcotic as abortive therapy for migraine, contrary to current recommendations (Gilmore and Michael. Am Fam Physician. 2011;83[3]:271-280). Use of opiates in these circumstances is problematic, and yet opiates are still often prescribed as first-line agents in some practices.
If this were a headache of moderate to severe intensity, triptans would have been the preferred abortive agent. No evidence was presented that this 39-year-old patient had a contraindication to triptans, dihydroergotamine, isometheptene, or intranasal lidocaine. He was given narcotics as first-line treatment for migraine.
Migraine can be extraordinarily painful, and we clinicians are ethically and legally bound to offer the best treatment available to arrest that pain. For most patients, high-dose parenteral narcotics are not favored for the management of migraine because of the potential for precipitating rebound headaches and because opiate dependence can lead to continuing, escalating demands for more narcotic intervention—and worsening headaches.
In this case, the dose of 14 mg of hydromorphone administered over 1 hour and 16 minutes is staggering—even for a patient who is not opiate-naïve. Further, in the IM route of administration (compared with IV), absorption and peak effect are imprecise. Even if the clinician were to argue that the patient’s narcotic tolerance necessitated this dose, the clinician was compelled to ensure that the patient was adequately monitored.
Migraine will become the clinician’s headache if the approach is nonchalant. First, always fully assess a patient with migraine to determine whether the headache is consistent with prior episodes; an atypical presentation may require neuroimaging or an alternate diagnostic approach. Second, always perform a proper examination, even when the headache is described as typical. Third, offer therapeutic interventions that follow evidence-based guidelines. Opiate use should be offered (if at all) at the end of a treatment algorithm.
For patients with putative allergies to all abortive treatments other than narcotics, it is wise for a neurologist or pain management group to evaluate the patient and establish a solid, agreed-upon treatment plan. This plan should acknowledge that more appropriate treatment is unavailable, that the patient has been fully informed of the risks and limitations of opiate agents, and that the patient agrees to follow this clearly defined plan.
Like hydromorphone and other opiate agents, meperidine is another drug with issues. Though still prescribed by some, meperidine is in specific disfavor because of the abuse potential and the risk for seizures induced by normeperidine (a metabolite of meperidine). Its once-touted benefit—avoidance of sphincter of Oddi spasm—is mythical and not a valid reason to keep meperidine stocked. A last highly specialized use may be to treat severe refractory rigors—but it is safe to say that meperidine should be closer to a museum for antiquated medications than to your migraine patient. Jurors will fault clinicians when patients become addicted or have seizures when safer options exist. Don’t use it.
Improve your management of migraine patients and lower your malpractice risk by performing a full assessment and following evidence-based guidelines to choose appropriate agents. In any case in which high-dose narcotics must be administered to abort a high-intensity migraine, a jury will expect the patient to be carefully monitored for respiratory depression until his/her sensorium is fully cleared following the agent’s peak effect.
Simply put, opiates must not be given in ambulatory settings in which the patient is expected to be discharged after 20 to 30 minutes of observation. This medication is not a flu shot, and the plaintiff’s attorney will hammer this point home if your narcotized migraine patient leaves your practice setting and steps in front of a vehicle. Protect the patient and avoid malpractice risk. —DML
Woman Given Morphine Despite Well-Documented Allergy
A 66-year-old Utah woman underwent surgery at the defendant hospital. The defendant surgeon ordered morphine to be administered following surgery—despite documentation in the patient’s record that she was allergic to morphine, and despite the fact that she was wearing a wristband indicating that she was allergic to morphine. The morphine was administered by hospital nurses over the course of several hours.
The patient became asystolic about 14 hours after receiving the first dose. She was revived but had suffered anoxic brain injury. She died two days later.
The decedent’s son-in-law alleged that he had seen a hospital employee remove the wristband indicating her allergy to morphine and throw it into the wastebasket; the son-in-law retrieved it.
The plaintiffs also claimed that a review of the medical record showed that the word “morphine” had been erased under the section entitled “Allergies.” This was discovered in a comparison of the hospital records with identical records supplied by one of the defendant doctors. In that doctor’s records, the word “morphine” was included.
OUTCOME
According to a published report, a confidential settlement was reached.
COMMENT
Because the settlement was confidential, we don’t know what the payment was—but we can be sure it was substantial.
Jurors abhor attempts to cover up mistakes, even when the jury pool is relatively conservative. Instead of viewing the matter as an error, jurors will impute the worst motives and will exact significant punitive damages. In Utah, for example, where this case occurred, punitive damages are not permitted unless the plaintiff can show by “clear and convincing evidence” that the defendants acted maliciously, with intentional fraudulence, or with reckless indifference toward the rights of others (Utah Code Ann §78-18-1).
This may be a case in which the clinician and staff succumbed to the stress of the moment and acted poorly and unprofessionally. Nevertheless, the staff members’ actions to cover up the mistake, by discarding the patient’s wristband that specified the allergy and erasing the note of the patient’s morphine allergy in the medical record, cause problems far beyond the initial mistake.
Because the malicious act (the cover-up activity) occurred after the fact, it did not directly injure the patient and could not form the basis for punitive damages in a malpractice action. However, the cover-up activity may be the basis for punitive damages for the family’s derivative “intentional infliction of emotional distress” claims. Generally, this type of claim must involve conduct that would prompt the average person hearing the facts to exclaim, “Outrageous!” That test is met here.
If presented with a case that may result in malpractice liability exposure, do not lose your head, blow your cool, or act rashly. Always act in the best interest of the patient and let the record reflect your efforts to protect the patient. Do not use the medical record for defensive discussion out of step with normal charting practices. Chart directly, dispassionately, and professionally, and avoid embellishment or hyperbole. Never alter, destroy, or conceal records.
Furthermore, do not react defensively or with hostility, and do not discuss the case openly during or immediately after the incident; any statements you make may be directly admissible against you or others as evidence. Do not initiate an “incident report” or otherwise “write up” a fellow worker: These documents are business records that will be discoverable by a plaintiff’s attorney, and they can be used against you, the facility, and your peers.
Likewise, the patient’s bedside is not the place for emotional discussions; there, the patient’s well-being must be the only concern. Instead, use the special process that was created to candidly and confidentially discuss matters of patient quality of care: the peer-review process. This process offers an appropriate setting to challenge treatment, question decisions, express remorse or misgivings, and cry, if needed. Ultimately, the peer review process is designed to improve patient care, and the plaintiff’s attorney cannot force disclosure of these discussions. If the plaintiff’s attorney asks questions about the substance of a peer review committee meeting, defense counsel will object on the basis of peer review privilege and block that inquiry.
In sum, should a mistake occur, do not panic. Protect the patient, and plan to discuss the case at a formal closed-door peer review conference. Note: As peer review law varies state by state, be sure that your peer review–related actions fall within your state’s defined scope of privilege. —DML
Cases reprinted with permission from Medical Malpractice Verdicts, Settlements and Experts, Lewis Laska, Editor, (800) 298-6288.
Excessive Dosing, Inadequate Monitoring Blamed in Death
A 39-year-old man with a history of pain complaints went to a Virginia hospital emergency department (ED) with a migraine. The defendant attending physician ordered IV medications; however, after several unsuccessful attempts to establish an IV line, the treating nurse administered 8 mg hydromorphone intramuscularly (IM). The patient was given a second dose of hydromorphone (6 mg IM) about an hour later before being transferred to a nonemergent room; there, he fell asleep. Loud snoring was noted, but the nurse responsible for monitoring the patient was not alarmed.
The patient then experienced respiratory arrest. Attempts to resuscitate him were unsuccessful.
Plaintiff for the decedent alleged negligence in improperly monitoring him and in failing to recognize signs of distress in a timely fashion. The plaintiff also claimed that the second dose overmedicated the decedent, leading to respiratory arrest. The plaintiff alleged negligence by the attending physician for ordering the second dose of hydromorphone and for transferring the decedent from the ED to a nonemergent room.
The claims against the defendant attending physician went to trial. The defendant claimed that the decedent was stable and showed no signs of acute distress at the time of transfer.
OUTCOME
The hospital settled for a confidential amount prior to trial. According to a published account, a defense verdict was returned in the trial against the attending physician.
COMMENT
This patient was given hydromorphone 8 mg IM at 5:55 am and hydromorphone 6 mg IM at 7:11 am as first-line treatment for migraine. He was discharged from the ED 10 minutes after receiving the second dose and transported to a gastroenterology suite for a previously scheduled colonoscopy. There, he was sparsely monitored, became apneic, and died.
Was the standard of care breached in this case?
The patient appears to have been offered a high-dose narcotic as abortive therapy for migraine, contrary to current recommendations (Gilmore and Michael. Am Fam Physician. 2011;83[3]:271-280). Use of opiates in these circumstances is problematic, and yet opiates are still often prescribed as first-line agents in some practices.
If this were a headache of moderate to severe intensity, triptans would have been the preferred abortive agent. No evidence was presented that this 39-year-old patient had a contraindication to triptans, dihydroergotamine, isometheptene, or intranasal lidocaine. He was given narcotics as first-line treatment for migraine.
Migraine can be extraordinarily painful, and we clinicians are ethically and legally bound to offer the best treatment available to arrest that pain. For most patients, high-dose parenteral narcotics are not favored for the management of migraine because of the potential for precipitating rebound headaches and because opiate dependence can lead to continuing, escalating demands for more narcotic intervention—and worsening headaches.
In this case, the dose of 14 mg of hydromorphone administered over 1 hour and 16 minutes is staggering—even for a patient who is not opiate-naïve. Further, in the IM route of administration (compared with IV), absorption and peak effect are imprecise. Even if the clinician were to argue that the patient’s narcotic tolerance necessitated this dose, the clinician was compelled to ensure that the patient was adequately monitored.
Migraine will become the clinician’s headache if the approach is nonchalant. First, always fully assess a patient with migraine to determine whether the headache is consistent with prior episodes; an atypical presentation may require neuroimaging or an alternate diagnostic approach. Second, always perform a proper examination, even when the headache is described as typical. Third, offer therapeutic interventions that follow evidence-based guidelines. Opiate use should be offered (if at all) at the end of a treatment algorithm.
For patients with putative allergies to all abortive treatments other than narcotics, it is wise for a neurologist or pain management group to evaluate the patient and establish a solid, agreed-upon treatment plan. This plan should acknowledge that more appropriate treatment is unavailable, that the patient has been fully informed of the risks and limitations of opiate agents, and that the patient agrees to follow this clearly defined plan.
Like hydromorphone and other opiate agents, meperidine is another drug with issues. Though still prescribed by some, meperidine is in specific disfavor because of the abuse potential and the risk for seizures induced by normeperidine (a metabolite of meperidine). Its once-touted benefit—avoidance of sphincter of Oddi spasm—is mythical and not a valid reason to keep meperidine stocked. A last highly specialized use may be to treat severe refractory rigors—but it is safe to say that meperidine should be closer to a museum for antiquated medications than to your migraine patient. Jurors will fault clinicians when patients become addicted or have seizures when safer options exist. Don’t use it.
Improve your management of migraine patients and lower your malpractice risk by performing a full assessment and following evidence-based guidelines to choose appropriate agents. In any case in which high-dose narcotics must be administered to abort a high-intensity migraine, a jury will expect the patient to be carefully monitored for respiratory depression until his/her sensorium is fully cleared following the agent’s peak effect.
Simply put, opiates must not be given in ambulatory settings in which the patient is expected to be discharged after 20 to 30 minutes of observation. This medication is not a flu shot, and the plaintiff’s attorney will hammer this point home if your narcotized migraine patient leaves your practice setting and steps in front of a vehicle. Protect the patient and avoid malpractice risk. —DML
Woman Given Morphine Despite Well-Documented Allergy
A 66-year-old Utah woman underwent surgery at the defendant hospital. The defendant surgeon ordered morphine to be administered following surgery—despite documentation in the patient’s record that she was allergic to morphine, and despite the fact that she was wearing a wristband indicating that she was allergic to morphine. The morphine was administered by hospital nurses over the course of several hours.
The patient became asystolic about 14 hours after receiving the first dose. She was revived but had suffered anoxic brain injury. She died two days later.
The decedent’s son-in-law alleged that he had seen a hospital employee remove the wristband indicating her allergy to morphine and throw it into the wastebasket; the son-in-law retrieved it.
The plaintiffs also claimed that a review of the medical record showed that the word “morphine” had been erased under the section entitled “Allergies.” This was discovered in a comparison of the hospital records with identical records supplied by one of the defendant doctors. In that doctor’s records, the word “morphine” was included.
OUTCOME
According to a published report, a confidential settlement was reached.
COMMENT
Because the settlement was confidential, we don’t know what the payment was—but we can be sure it was substantial.
Jurors abhor attempts to cover up mistakes, even when the jury pool is relatively conservative. Instead of viewing the matter as an error, jurors will impute the worst motives and will exact significant punitive damages. In Utah, for example, where this case occurred, punitive damages are not permitted unless the plaintiff can show by “clear and convincing evidence” that the defendants acted maliciously, with intentional fraudulence, or with reckless indifference toward the rights of others (Utah Code Ann §78-18-1).
This may be a case in which the clinician and staff succumbed to the stress of the moment and acted poorly and unprofessionally. Nevertheless, the staff members’ actions to cover up the mistake, by discarding the patient’s wristband that specified the allergy and erasing the note of the patient’s morphine allergy in the medical record, cause problems far beyond the initial mistake.
Because the malicious act (the cover-up activity) occurred after the fact, it did not directly injure the patient and could not form the basis for punitive damages in a malpractice action. However, the cover-up activity may be the basis for punitive damages for the family’s derivative “intentional infliction of emotional distress” claims. Generally, this type of claim must involve conduct that would prompt the average person hearing the facts to exclaim, “Outrageous!” That test is met here.
If presented with a case that may result in malpractice liability exposure, do not lose your head, blow your cool, or act rashly. Always act in the best interest of the patient and let the record reflect your efforts to protect the patient. Do not use the medical record for defensive discussion out of step with normal charting practices. Chart directly, dispassionately, and professionally, and avoid embellishment or hyperbole. Never alter, destroy, or conceal records.
Furthermore, do not react defensively or with hostility, and do not discuss the case openly during or immediately after the incident; any statements you make may be directly admissible against you or others as evidence. Do not initiate an “incident report” or otherwise “write up” a fellow worker: These documents are business records that will be discoverable by a plaintiff’s attorney, and they can be used against you, the facility, and your peers.
Likewise, the patient’s bedside is not the place for emotional discussions; there, the patient’s well-being must be the only concern. Instead, use the special process that was created to candidly and confidentially discuss matters of patient quality of care: the peer-review process. This process offers an appropriate setting to challenge treatment, question decisions, express remorse or misgivings, and cry, if needed. Ultimately, the peer review process is designed to improve patient care, and the plaintiff’s attorney cannot force disclosure of these discussions. If the plaintiff’s attorney asks questions about the substance of a peer review committee meeting, defense counsel will object on the basis of peer review privilege and block that inquiry.
In sum, should a mistake occur, do not panic. Protect the patient, and plan to discuss the case at a formal closed-door peer review conference. Note: As peer review law varies state by state, be sure that your peer review–related actions fall within your state’s defined scope of privilege. —DML
Cases reprinted with permission from Medical Malpractice Verdicts, Settlements and Experts, Lewis Laska, Editor, (800) 298-6288.
Excessive Dosing, Inadequate Monitoring Blamed in Death
A 39-year-old man with a history of pain complaints went to a Virginia hospital emergency department (ED) with a migraine. The defendant attending physician ordered IV medications; however, after several unsuccessful attempts to establish an IV line, the treating nurse administered 8 mg hydromorphone intramuscularly (IM). The patient was given a second dose of hydromorphone (6 mg IM) about an hour later before being transferred to a nonemergent room; there, he fell asleep. Loud snoring was noted, but the nurse responsible for monitoring the patient was not alarmed.
The patient then experienced respiratory arrest. Attempts to resuscitate him were unsuccessful.
Plaintiff for the decedent alleged negligence in improperly monitoring him and in failing to recognize signs of distress in a timely fashion. The plaintiff also claimed that the second dose overmedicated the decedent, leading to respiratory arrest. The plaintiff alleged negligence by the attending physician for ordering the second dose of hydromorphone and for transferring the decedent from the ED to a nonemergent room.
The claims against the defendant attending physician went to trial. The defendant claimed that the decedent was stable and showed no signs of acute distress at the time of transfer.
OUTCOME
The hospital settled for a confidential amount prior to trial. According to a published account, a defense verdict was returned in the trial against the attending physician.
COMMENT
This patient was given hydromorphone 8 mg IM at 5:55 am and hydromorphone 6 mg IM at 7:11 am as first-line treatment for migraine. He was discharged from the ED 10 minutes after receiving the second dose and transported to a gastroenterology suite for a previously scheduled colonoscopy. There, he was sparsely monitored, became apneic, and died.
Was the standard of care breached in this case?
The patient appears to have been offered a high-dose narcotic as abortive therapy for migraine, contrary to current recommendations (Gilmore and Michael. Am Fam Physician. 2011;83[3]:271-280). Use of opiates in these circumstances is problematic, and yet opiates are still often prescribed as first-line agents in some practices.
If this were a headache of moderate to severe intensity, triptans would have been the preferred abortive agent. No evidence was presented that this 39-year-old patient had a contraindication to triptans, dihydroergotamine, isometheptene, or intranasal lidocaine. He was given narcotics as first-line treatment for migraine.
Migraine can be extraordinarily painful, and we clinicians are ethically and legally bound to offer the best treatment available to arrest that pain. For most patients, high-dose parenteral narcotics are not favored for the management of migraine because of the potential for precipitating rebound headaches and because opiate dependence can lead to continuing, escalating demands for more narcotic intervention—and worsening headaches.
In this case, the dose of 14 mg of hydromorphone administered over 1 hour and 16 minutes is staggering—even for a patient who is not opiate-naïve. Further, in the IM route of administration (compared with IV), absorption and peak effect are imprecise. Even if the clinician were to argue that the patient’s narcotic tolerance necessitated this dose, the clinician was compelled to ensure that the patient was adequately monitored.
Migraine will become the clinician’s headache if the approach is nonchalant. First, always fully assess a patient with migraine to determine whether the headache is consistent with prior episodes; an atypical presentation may require neuroimaging or an alternate diagnostic approach. Second, always perform a proper examination, even when the headache is described as typical. Third, offer therapeutic interventions that follow evidence-based guidelines. Opiate use should be offered (if at all) at the end of a treatment algorithm.
For patients with putative allergies to all abortive treatments other than narcotics, it is wise for a neurologist or pain management group to evaluate the patient and establish a solid, agreed-upon treatment plan. This plan should acknowledge that more appropriate treatment is unavailable, that the patient has been fully informed of the risks and limitations of opiate agents, and that the patient agrees to follow this clearly defined plan.
Like hydromorphone and other opiate agents, meperidine is another drug with issues. Though still prescribed by some, meperidine is in specific disfavor because of the abuse potential and the risk for seizures induced by normeperidine (a metabolite of meperidine). Its once-touted benefit—avoidance of sphincter of Oddi spasm—is mythical and not a valid reason to keep meperidine stocked. A last highly specialized use may be to treat severe refractory rigors—but it is safe to say that meperidine should be closer to a museum for antiquated medications than to your migraine patient. Jurors will fault clinicians when patients become addicted or have seizures when safer options exist. Don’t use it.
Improve your management of migraine patients and lower your malpractice risk by performing a full assessment and following evidence-based guidelines to choose appropriate agents. In any case in which high-dose narcotics must be administered to abort a high-intensity migraine, a jury will expect the patient to be carefully monitored for respiratory depression until his/her sensorium is fully cleared following the agent’s peak effect.
Simply put, opiates must not be given in ambulatory settings in which the patient is expected to be discharged after 20 to 30 minutes of observation. This medication is not a flu shot, and the plaintiff’s attorney will hammer this point home if your narcotized migraine patient leaves your practice setting and steps in front of a vehicle. Protect the patient and avoid malpractice risk. —DML
Woman Given Morphine Despite Well-Documented Allergy
A 66-year-old Utah woman underwent surgery at the defendant hospital. The defendant surgeon ordered morphine to be administered following surgery—despite documentation in the patient’s record that she was allergic to morphine, and despite the fact that she was wearing a wristband indicating that she was allergic to morphine. The morphine was administered by hospital nurses over the course of several hours.
The patient became asystolic about 14 hours after receiving the first dose. She was revived but had suffered anoxic brain injury. She died two days later.
The decedent’s son-in-law alleged that he had seen a hospital employee remove the wristband indicating her allergy to morphine and throw it into the wastebasket; the son-in-law retrieved it.
The plaintiffs also claimed that a review of the medical record showed that the word “morphine” had been erased under the section entitled “Allergies.” This was discovered in a comparison of the hospital records with identical records supplied by one of the defendant doctors. In that doctor’s records, the word “morphine” was included.
OUTCOME
According to a published report, a confidential settlement was reached.
COMMENT
Because the settlement was confidential, we don’t know what the payment was—but we can be sure it was substantial.
Jurors abhor attempts to cover up mistakes, even when the jury pool is relatively conservative. Instead of viewing the matter as an error, jurors will impute the worst motives and will exact significant punitive damages. In Utah, for example, where this case occurred, punitive damages are not permitted unless the plaintiff can show by “clear and convincing evidence” that the defendants acted maliciously, with intentional fraudulence, or with reckless indifference toward the rights of others (Utah Code Ann §78-18-1).
This may be a case in which the clinician and staff succumbed to the stress of the moment and acted poorly and unprofessionally. Nevertheless, the staff members’ actions to cover up the mistake, by discarding the patient’s wristband that specified the allergy and erasing the note of the patient’s morphine allergy in the medical record, cause problems far beyond the initial mistake.
Because the malicious act (the cover-up activity) occurred after the fact, it did not directly injure the patient and could not form the basis for punitive damages in a malpractice action. However, the cover-up activity may be the basis for punitive damages for the family’s derivative “intentional infliction of emotional distress” claims. Generally, this type of claim must involve conduct that would prompt the average person hearing the facts to exclaim, “Outrageous!” That test is met here.
If presented with a case that may result in malpractice liability exposure, do not lose your head, blow your cool, or act rashly. Always act in the best interest of the patient and let the record reflect your efforts to protect the patient. Do not use the medical record for defensive discussion out of step with normal charting practices. Chart directly, dispassionately, and professionally, and avoid embellishment or hyperbole. Never alter, destroy, or conceal records.
Furthermore, do not react defensively or with hostility, and do not discuss the case openly during or immediately after the incident; any statements you make may be directly admissible against you or others as evidence. Do not initiate an “incident report” or otherwise “write up” a fellow worker: These documents are business records that will be discoverable by a plaintiff’s attorney, and they can be used against you, the facility, and your peers.
Likewise, the patient’s bedside is not the place for emotional discussions; there, the patient’s well-being must be the only concern. Instead, use the special process that was created to candidly and confidentially discuss matters of patient quality of care: the peer-review process. This process offers an appropriate setting to challenge treatment, question decisions, express remorse or misgivings, and cry, if needed. Ultimately, the peer review process is designed to improve patient care, and the plaintiff’s attorney cannot force disclosure of these discussions. If the plaintiff’s attorney asks questions about the substance of a peer review committee meeting, defense counsel will object on the basis of peer review privilege and block that inquiry.
In sum, should a mistake occur, do not panic. Protect the patient, and plan to discuss the case at a formal closed-door peer review conference. Note: As peer review law varies state by state, be sure that your peer review–related actions fall within your state’s defined scope of privilege. —DML
Cases reprinted with permission from Medical Malpractice Verdicts, Settlements and Experts, Lewis Laska, Editor, (800) 298-6288.
Infant’s brain damage blamed on delayed delivery … and more
DURING DELIVERY, THE MOTHER’S PERINATOLOGIST recognized a severe shoulder dystocia. The perinatologist abandoned vaginal delivery and ordered an emergency cesarean delivery. The mother was transferred to an operating room (OR) with the baby’s head out between her legs. In the OR, the perinatologist pushed the baby’s head back into the uterus and performed a cesarean extraction. Nineteen minutes elapsed from when the vaginal delivery was abandoned and the baby was delivered.
The child was unresponsive at birth with no spontaneous movement or respiration. She was intubated and transferred to the NICU, where she was resuscitated. MRI confirmed that the child had hypoxic ischemia and severe, permanent brain damage from acute birth asphyxia. The child is blind, deaf, hypertensive, and has diffuse spasticity. She has a tracheostomy, a gastrostomy tube, and requires 24-hour care.
PARENTS’ CLAIM The perinatologist was negligent for abandoning vaginal delivery when delivery was progressing appropriately and there was no fetal distress. If the perinatologist had rotated the baby’s shoulder to the oblique position and/or used suprapubic pressure, the shoulder would have become disimpacted and the baby would have been safely delivered within seconds. Delay in delivery allowed for 19 minutes of umbilical cord compression, resulting in brain damage.
PHYSICIAN’S DEFENSE Cesarean delivery was appropriate; the baby did not suffer cord compression. Injury to the brain occurred days before delivery, based on prenatal ultrasonography.
VERDICT A $5.5 million California settlement was reached.
Failure to diagnose breast cancer: death
A 38-YEAR-OLD WOMAN went to her primary care physician (PCP) 3 years after giving birth. She reported breast pain, nipple discharge, and a dime-sized lump. The woman was still breastfeeding. An exam by the nurse practitioner (NP) was limited because the patient had breast implants. The NP suspected a galactocele and advised the patient to stop breastfeeding and apply ice packs. When the patient returned in 2 weeks, only the lump remained. The PCP determined that she had mastitis.
Five months later, she returned with additional lumps in both breasts, and was referred to a gynecologist. Ultrasonography (US) was ordered, but the patient never followed up. A year later, the patient was found to have metastatic breast cancer and died after 3 years of treatment.
ESTATE’S CLAIM The PCP and NP were negligent for not referring her for a breast biopsy when a lump was first detected.
DEFENDANTS’ DEFENSE Proper care was given. An earlier diagnosis would not have changed the outcome.
VERDICT A $750,000 Massachusetts settlement was reached.
What caused this child’s autism?
AFTER 33 HOURS OF LABOR, a baby was delivered vaginally by an ObGyn, nurse, and midwife. The child was diagnosed with autism several years later. His development is delayed, and he suffers cognitive impairment.
PARENTS’ CLAIM The child’s autism is due to a prolonged hypoxic event during labor. Fetal heart-rate monitoring demonstrated fetal distress, with a bradycardia. A cesarean delivery should have been performed.
PHYSICIAN’S DEFENSE The child has genetic autism unrelated to the birth process.
VERDICT A $1.35 million New York settlement was reached.
Was oxytocin the culprit?
DURING AN EXTENDED LABOR, the ObGyn continued to give the mother oxytocin, although there were signs of fetal distress. The child was born with brain damage, cannot walk, talk, or see, and requires 24-hour care.
PATIENT’S CLAIM The use of oxytocin was inappropriate given the signs of fetal distress. Oxytocin caused a lack of oxygen to the child, resulting in brain damage. A cesarean delivery should have been performed when fetal distress was identified.
DEFENDANTS’ DEFENSE The case was settled before trial.
VERDICT A $12 million Illinois settlement was reached: $11 million from the hospital and $1 million from the ObGyn.
DURING LEFT OOPHORECTOMY, the ObGyn encountered adhesions. Five days later, the 41-year-old patient reported severe pain. A second procedure revealed sepsis and perforation of the large bowel. A colostomy was performed. The patient underwent additional corrective operations.
PATIENT’S CLAIM The ObGyn was negligent for causing tissue damage to the colon that perforated and escalated into sepsis. A surgeon should have been consulted when the ObGyn found the adhesions, so the bowel could be properly inspected before the abdomen was closed. The physician was also negligent for not recognizing symptoms of sepsis earlier.
PHYSICIAN’S DEFENSE Bowel injury is a known complication of oophorectomy. The patient appeared to be making a fairly good recovery until infection became evident; she was immediately treated.
VERDICT A $6.3 million New Jersey verdict was returned, including $300,000 for the husband’s loss of consortium.
Traumatic delivery causes seizures
DURING CESAREAN DELIVERY, the ObGyn rotated the baby from a transverse to a cephalic lie, and used a vacuum extractor to deliver the head through the hysterotomy incision.
When the child was 25 hours old, he suffered a seizure that lasted 6 minutes. Focal seizure activity involving the left side of his body and a skull fracture were identified. He was transferred to another hospital, where radiologic studies indicated a middle right cerebral artery infarct. The child developed an ongoing seizure disorder, speech and language delays, and mild, left-sided weakness.
PARENTS’ CLAIM The baby’s head was not properly delivered through the cesarean incision nor should the ObGyn have used vacuum extraction. The combination of the rotation and use of vacuum caused trauma to the infant’s head. In addition, the baby was placed in the well-baby nursery, which was inappropriate because he was born through thick meconium, resuscitated by a neonatal nurse, and had a depressed skull fracture.
PHYSICIAN’S DEFENSE Delivery was not traumatic; all treatment was appropriate.
VERDICT A $4.6 million New York settlement was reached with the hospital and ObGyn’s insurer.
Mother gets severe headache during birth
A 35-YEAR-OLD WOMAN began having a severe headache during delivery that continued after birth. She was discharged from the hospital and collapsed at home a day later. She was returned to the ED, where she was left in a hallway for 6 hours. She lost consciousness while in the hallway. Imaging and neurologic evaluation determined that she suffered a hypoxic brain injury from intracranial bleeding. She has slow response time, difficulty with all aspects of everyday life, and requires full-time attendant care.
PATIENT’S CLAIM Although she complained of a headache, no testing was done prior to her hospital discharge. Treatment was extremely delayed in the ED; an earlier diagnosis could have prevented brain damage.
PHYSICIAN’S DEFENSE Nothing could have prevented the brain damage.
VERDICT A $3.5 million California settlement was mediated.
Shoulder dystocia; brachial plexus injury
WHEN SHOULDER DYSTOCIA was encountered during delivery, the ObGyn applied gentle pressure to deliver the head. He was assisted by an ObGyn resident. The child was born with a brachial plexus injury, causing left-arm paralysis. She underwent surgery that increased her range of motion, but she will need years of physical therapy.
PATIENT’S CLAIM The ObGyn applied excessive traction and the resident improperly applied fundal pressure.
DEFENDANTS’ DEFENSE Only gentle traction was used. The resident did not apply fundal pressure.
VERDICT A New York jury found the ObGyn at fault and awarded the patient $3.5 million. The resident was vindicated.
AN EXPECTANT MOTHER MISCARRIED AT HOME at 6 months’ gestation, and an ambulance was called. After the EMTs helped the mother to the ambulance, they retrieved the fetus. When the baby was seen moving its head, the EMTs requested assistance from the advanced life support (ALS) team. ALS personnel visually assessed the fetus, determined it was nonviable, and placed the baby in a small container. The mother and baby arrived at the hospital 17 minutes after the ambulance was called.
At the hospital, a nurse noticed that the fetus was warm and had a heartbeat. The baby was taken to a special-care nursery for resuscitation and then transferred to another hospital’s NICU. The baby died after 46 days from severe brain damage due to lack of oxygen.
PARENTS’ CLAIM The EMTs and ALS team should have provided better evaluation and treatment for the infant; they were not trained to determine an infant’s viability. Placing the infant inside a plastic bag inside a box with a lid further deprived the baby of oxygen.
DEFENDANTS’ DEFENSE The case was settled before trial.
VERDICT A $1 million Massachusetts settlement was reached.
Were records altered because of a delayed diagnosis?
A WOMAN FOUND A LUMP in her left breast. A gynecologist ordered mammography. In January 2006, the radiologist requested ultrasonography (US), and reported that it conclusively indicated that the mass was a cyst. The gynecologist told the patient the tests were normal; further action was unnecessary. The patient saw the gynecologist four more times before being referred to a breast surgeon. In June 2006, she underwent surgical resection and chemotherapy for a malignant breast tumor.
PATIENT’S CLAIM The gynecologist was negligent for not referring the patient to a surgeon earlier. The gynecologist altered records: excerpts from the mammogram and US reports had been scanned in with a notation that the gynecologist had told the patient to follow up with a surgeon. When the gynecologist faxed the same reports to the surgeon, the annotations were absent. The gynecologist also changed the December 2005 chart, which referred to an US she never ordered.
PHYSICIAN’S DEFENSE The gynecologist stated that she regularly “merged” two reports into one document in her practice.
VERDICT A $700,000 Pennsylvania verdict was returned.
Excessive force or standard of care?
SHOULDER DYSTOCIA occurred during labor. The child sustained left brachial plexus palsy. At age 6, his left arm is paralyzed and smaller than the right arm. He has trouble performing normal daily tasks.
PATIENT’S CLAIM The ObGyn used excessive force by pulling on the baby’s head to complete the delivery. Standard of care required the ObGyn to take a more gentle approach to achieve delivery.
PHYSICIAN’S DEFENSE Delivery was performed appropriately, and did not deviate from standard of care.
VERDICT A $20.881 million Maryland verdict was returned, including $20 million for pain and suffering. The total award was reduced to $1,531,082 when the pain and suffering award was cut to $650,000 under the state’s statutory cap.
Preterm birth from an asymptomatic UTI?
A BABY WAS BORN AT 31 WEEKS’ gestation. The child has cerebral palsy, spastic quadriplegia, and requires assistance in all aspects of life.
PARENTS’ CLAIM Chorioamnionitis from a urinary tract infection (UTI) caused preterm birth. Urinalysis performed 7 weeks earlier indicated an infection, but the second-year resident caring for the mother failed to treat the UTI. The resident should have obtained a confirming urine culture, prescribed antibiotics, and monitored the mother more closely. The resident was poorly supervised.
DEFENDANTS’ DEFENSE Chorioamnionitis developed just before birth and could not be detected or prevented. A UTI cannot remain asymptomatic for 7 weeks and still cause premature birth. The mother was at increased risk of premature delivery because she had given birth to an anencephalic infant a year earlier. She began prenatal care in the middle of her pregnancy and ignored a referral to a high-risk maternal fetal specialist.
VERDICT A New York defense verdict was returned.
These cases were selected by the editors of OBG Management from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska (www.verdictslaska.com). The information available to the editors about the cases presented here is sometimes incomplete. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.
We want to hear from you! Tell us what you think.
DURING DELIVERY, THE MOTHER’S PERINATOLOGIST recognized a severe shoulder dystocia. The perinatologist abandoned vaginal delivery and ordered an emergency cesarean delivery. The mother was transferred to an operating room (OR) with the baby’s head out between her legs. In the OR, the perinatologist pushed the baby’s head back into the uterus and performed a cesarean extraction. Nineteen minutes elapsed from when the vaginal delivery was abandoned and the baby was delivered.
The child was unresponsive at birth with no spontaneous movement or respiration. She was intubated and transferred to the NICU, where she was resuscitated. MRI confirmed that the child had hypoxic ischemia and severe, permanent brain damage from acute birth asphyxia. The child is blind, deaf, hypertensive, and has diffuse spasticity. She has a tracheostomy, a gastrostomy tube, and requires 24-hour care.
PARENTS’ CLAIM The perinatologist was negligent for abandoning vaginal delivery when delivery was progressing appropriately and there was no fetal distress. If the perinatologist had rotated the baby’s shoulder to the oblique position and/or used suprapubic pressure, the shoulder would have become disimpacted and the baby would have been safely delivered within seconds. Delay in delivery allowed for 19 minutes of umbilical cord compression, resulting in brain damage.
PHYSICIAN’S DEFENSE Cesarean delivery was appropriate; the baby did not suffer cord compression. Injury to the brain occurred days before delivery, based on prenatal ultrasonography.
VERDICT A $5.5 million California settlement was reached.
Failure to diagnose breast cancer: death
A 38-YEAR-OLD WOMAN went to her primary care physician (PCP) 3 years after giving birth. She reported breast pain, nipple discharge, and a dime-sized lump. The woman was still breastfeeding. An exam by the nurse practitioner (NP) was limited because the patient had breast implants. The NP suspected a galactocele and advised the patient to stop breastfeeding and apply ice packs. When the patient returned in 2 weeks, only the lump remained. The PCP determined that she had mastitis.
Five months later, she returned with additional lumps in both breasts, and was referred to a gynecologist. Ultrasonography (US) was ordered, but the patient never followed up. A year later, the patient was found to have metastatic breast cancer and died after 3 years of treatment.
ESTATE’S CLAIM The PCP and NP were negligent for not referring her for a breast biopsy when a lump was first detected.
DEFENDANTS’ DEFENSE Proper care was given. An earlier diagnosis would not have changed the outcome.
VERDICT A $750,000 Massachusetts settlement was reached.
What caused this child’s autism?
AFTER 33 HOURS OF LABOR, a baby was delivered vaginally by an ObGyn, nurse, and midwife. The child was diagnosed with autism several years later. His development is delayed, and he suffers cognitive impairment.
PARENTS’ CLAIM The child’s autism is due to a prolonged hypoxic event during labor. Fetal heart-rate monitoring demonstrated fetal distress, with a bradycardia. A cesarean delivery should have been performed.
PHYSICIAN’S DEFENSE The child has genetic autism unrelated to the birth process.
VERDICT A $1.35 million New York settlement was reached.
Was oxytocin the culprit?
DURING AN EXTENDED LABOR, the ObGyn continued to give the mother oxytocin, although there were signs of fetal distress. The child was born with brain damage, cannot walk, talk, or see, and requires 24-hour care.
PATIENT’S CLAIM The use of oxytocin was inappropriate given the signs of fetal distress. Oxytocin caused a lack of oxygen to the child, resulting in brain damage. A cesarean delivery should have been performed when fetal distress was identified.
DEFENDANTS’ DEFENSE The case was settled before trial.
VERDICT A $12 million Illinois settlement was reached: $11 million from the hospital and $1 million from the ObGyn.
DURING LEFT OOPHORECTOMY, the ObGyn encountered adhesions. Five days later, the 41-year-old patient reported severe pain. A second procedure revealed sepsis and perforation of the large bowel. A colostomy was performed. The patient underwent additional corrective operations.
PATIENT’S CLAIM The ObGyn was negligent for causing tissue damage to the colon that perforated and escalated into sepsis. A surgeon should have been consulted when the ObGyn found the adhesions, so the bowel could be properly inspected before the abdomen was closed. The physician was also negligent for not recognizing symptoms of sepsis earlier.
PHYSICIAN’S DEFENSE Bowel injury is a known complication of oophorectomy. The patient appeared to be making a fairly good recovery until infection became evident; she was immediately treated.
VERDICT A $6.3 million New Jersey verdict was returned, including $300,000 for the husband’s loss of consortium.
Traumatic delivery causes seizures
DURING CESAREAN DELIVERY, the ObGyn rotated the baby from a transverse to a cephalic lie, and used a vacuum extractor to deliver the head through the hysterotomy incision.
When the child was 25 hours old, he suffered a seizure that lasted 6 minutes. Focal seizure activity involving the left side of his body and a skull fracture were identified. He was transferred to another hospital, where radiologic studies indicated a middle right cerebral artery infarct. The child developed an ongoing seizure disorder, speech and language delays, and mild, left-sided weakness.
PARENTS’ CLAIM The baby’s head was not properly delivered through the cesarean incision nor should the ObGyn have used vacuum extraction. The combination of the rotation and use of vacuum caused trauma to the infant’s head. In addition, the baby was placed in the well-baby nursery, which was inappropriate because he was born through thick meconium, resuscitated by a neonatal nurse, and had a depressed skull fracture.
PHYSICIAN’S DEFENSE Delivery was not traumatic; all treatment was appropriate.
VERDICT A $4.6 million New York settlement was reached with the hospital and ObGyn’s insurer.
Mother gets severe headache during birth
A 35-YEAR-OLD WOMAN began having a severe headache during delivery that continued after birth. She was discharged from the hospital and collapsed at home a day later. She was returned to the ED, where she was left in a hallway for 6 hours. She lost consciousness while in the hallway. Imaging and neurologic evaluation determined that she suffered a hypoxic brain injury from intracranial bleeding. She has slow response time, difficulty with all aspects of everyday life, and requires full-time attendant care.
PATIENT’S CLAIM Although she complained of a headache, no testing was done prior to her hospital discharge. Treatment was extremely delayed in the ED; an earlier diagnosis could have prevented brain damage.
PHYSICIAN’S DEFENSE Nothing could have prevented the brain damage.
VERDICT A $3.5 million California settlement was mediated.
Shoulder dystocia; brachial plexus injury
WHEN SHOULDER DYSTOCIA was encountered during delivery, the ObGyn applied gentle pressure to deliver the head. He was assisted by an ObGyn resident. The child was born with a brachial plexus injury, causing left-arm paralysis. She underwent surgery that increased her range of motion, but she will need years of physical therapy.
PATIENT’S CLAIM The ObGyn applied excessive traction and the resident improperly applied fundal pressure.
DEFENDANTS’ DEFENSE Only gentle traction was used. The resident did not apply fundal pressure.
VERDICT A New York jury found the ObGyn at fault and awarded the patient $3.5 million. The resident was vindicated.
AN EXPECTANT MOTHER MISCARRIED AT HOME at 6 months’ gestation, and an ambulance was called. After the EMTs helped the mother to the ambulance, they retrieved the fetus. When the baby was seen moving its head, the EMTs requested assistance from the advanced life support (ALS) team. ALS personnel visually assessed the fetus, determined it was nonviable, and placed the baby in a small container. The mother and baby arrived at the hospital 17 minutes after the ambulance was called.
At the hospital, a nurse noticed that the fetus was warm and had a heartbeat. The baby was taken to a special-care nursery for resuscitation and then transferred to another hospital’s NICU. The baby died after 46 days from severe brain damage due to lack of oxygen.
PARENTS’ CLAIM The EMTs and ALS team should have provided better evaluation and treatment for the infant; they were not trained to determine an infant’s viability. Placing the infant inside a plastic bag inside a box with a lid further deprived the baby of oxygen.
DEFENDANTS’ DEFENSE The case was settled before trial.
VERDICT A $1 million Massachusetts settlement was reached.
Were records altered because of a delayed diagnosis?
A WOMAN FOUND A LUMP in her left breast. A gynecologist ordered mammography. In January 2006, the radiologist requested ultrasonography (US), and reported that it conclusively indicated that the mass was a cyst. The gynecologist told the patient the tests were normal; further action was unnecessary. The patient saw the gynecologist four more times before being referred to a breast surgeon. In June 2006, she underwent surgical resection and chemotherapy for a malignant breast tumor.
PATIENT’S CLAIM The gynecologist was negligent for not referring the patient to a surgeon earlier. The gynecologist altered records: excerpts from the mammogram and US reports had been scanned in with a notation that the gynecologist had told the patient to follow up with a surgeon. When the gynecologist faxed the same reports to the surgeon, the annotations were absent. The gynecologist also changed the December 2005 chart, which referred to an US she never ordered.
PHYSICIAN’S DEFENSE The gynecologist stated that she regularly “merged” two reports into one document in her practice.
VERDICT A $700,000 Pennsylvania verdict was returned.
Excessive force or standard of care?
SHOULDER DYSTOCIA occurred during labor. The child sustained left brachial plexus palsy. At age 6, his left arm is paralyzed and smaller than the right arm. He has trouble performing normal daily tasks.
PATIENT’S CLAIM The ObGyn used excessive force by pulling on the baby’s head to complete the delivery. Standard of care required the ObGyn to take a more gentle approach to achieve delivery.
PHYSICIAN’S DEFENSE Delivery was performed appropriately, and did not deviate from standard of care.
VERDICT A $20.881 million Maryland verdict was returned, including $20 million for pain and suffering. The total award was reduced to $1,531,082 when the pain and suffering award was cut to $650,000 under the state’s statutory cap.
Preterm birth from an asymptomatic UTI?
A BABY WAS BORN AT 31 WEEKS’ gestation. The child has cerebral palsy, spastic quadriplegia, and requires assistance in all aspects of life.
PARENTS’ CLAIM Chorioamnionitis from a urinary tract infection (UTI) caused preterm birth. Urinalysis performed 7 weeks earlier indicated an infection, but the second-year resident caring for the mother failed to treat the UTI. The resident should have obtained a confirming urine culture, prescribed antibiotics, and monitored the mother more closely. The resident was poorly supervised.
DEFENDANTS’ DEFENSE Chorioamnionitis developed just before birth and could not be detected or prevented. A UTI cannot remain asymptomatic for 7 weeks and still cause premature birth. The mother was at increased risk of premature delivery because she had given birth to an anencephalic infant a year earlier. She began prenatal care in the middle of her pregnancy and ignored a referral to a high-risk maternal fetal specialist.
VERDICT A New York defense verdict was returned.
DURING DELIVERY, THE MOTHER’S PERINATOLOGIST recognized a severe shoulder dystocia. The perinatologist abandoned vaginal delivery and ordered an emergency cesarean delivery. The mother was transferred to an operating room (OR) with the baby’s head out between her legs. In the OR, the perinatologist pushed the baby’s head back into the uterus and performed a cesarean extraction. Nineteen minutes elapsed from when the vaginal delivery was abandoned and the baby was delivered.
The child was unresponsive at birth with no spontaneous movement or respiration. She was intubated and transferred to the NICU, where she was resuscitated. MRI confirmed that the child had hypoxic ischemia and severe, permanent brain damage from acute birth asphyxia. The child is blind, deaf, hypertensive, and has diffuse spasticity. She has a tracheostomy, a gastrostomy tube, and requires 24-hour care.
PARENTS’ CLAIM The perinatologist was negligent for abandoning vaginal delivery when delivery was progressing appropriately and there was no fetal distress. If the perinatologist had rotated the baby’s shoulder to the oblique position and/or used suprapubic pressure, the shoulder would have become disimpacted and the baby would have been safely delivered within seconds. Delay in delivery allowed for 19 minutes of umbilical cord compression, resulting in brain damage.
PHYSICIAN’S DEFENSE Cesarean delivery was appropriate; the baby did not suffer cord compression. Injury to the brain occurred days before delivery, based on prenatal ultrasonography.
VERDICT A $5.5 million California settlement was reached.
Failure to diagnose breast cancer: death
A 38-YEAR-OLD WOMAN went to her primary care physician (PCP) 3 years after giving birth. She reported breast pain, nipple discharge, and a dime-sized lump. The woman was still breastfeeding. An exam by the nurse practitioner (NP) was limited because the patient had breast implants. The NP suspected a galactocele and advised the patient to stop breastfeeding and apply ice packs. When the patient returned in 2 weeks, only the lump remained. The PCP determined that she had mastitis.
Five months later, she returned with additional lumps in both breasts, and was referred to a gynecologist. Ultrasonography (US) was ordered, but the patient never followed up. A year later, the patient was found to have metastatic breast cancer and died after 3 years of treatment.
ESTATE’S CLAIM The PCP and NP were negligent for not referring her for a breast biopsy when a lump was first detected.
DEFENDANTS’ DEFENSE Proper care was given. An earlier diagnosis would not have changed the outcome.
VERDICT A $750,000 Massachusetts settlement was reached.
What caused this child’s autism?
AFTER 33 HOURS OF LABOR, a baby was delivered vaginally by an ObGyn, nurse, and midwife. The child was diagnosed with autism several years later. His development is delayed, and he suffers cognitive impairment.
PARENTS’ CLAIM The child’s autism is due to a prolonged hypoxic event during labor. Fetal heart-rate monitoring demonstrated fetal distress, with a bradycardia. A cesarean delivery should have been performed.
PHYSICIAN’S DEFENSE The child has genetic autism unrelated to the birth process.
VERDICT A $1.35 million New York settlement was reached.
Was oxytocin the culprit?
DURING AN EXTENDED LABOR, the ObGyn continued to give the mother oxytocin, although there were signs of fetal distress. The child was born with brain damage, cannot walk, talk, or see, and requires 24-hour care.
PATIENT’S CLAIM The use of oxytocin was inappropriate given the signs of fetal distress. Oxytocin caused a lack of oxygen to the child, resulting in brain damage. A cesarean delivery should have been performed when fetal distress was identified.
DEFENDANTS’ DEFENSE The case was settled before trial.
VERDICT A $12 million Illinois settlement was reached: $11 million from the hospital and $1 million from the ObGyn.
DURING LEFT OOPHORECTOMY, the ObGyn encountered adhesions. Five days later, the 41-year-old patient reported severe pain. A second procedure revealed sepsis and perforation of the large bowel. A colostomy was performed. The patient underwent additional corrective operations.
PATIENT’S CLAIM The ObGyn was negligent for causing tissue damage to the colon that perforated and escalated into sepsis. A surgeon should have been consulted when the ObGyn found the adhesions, so the bowel could be properly inspected before the abdomen was closed. The physician was also negligent for not recognizing symptoms of sepsis earlier.
PHYSICIAN’S DEFENSE Bowel injury is a known complication of oophorectomy. The patient appeared to be making a fairly good recovery until infection became evident; she was immediately treated.
VERDICT A $6.3 million New Jersey verdict was returned, including $300,000 for the husband’s loss of consortium.
Traumatic delivery causes seizures
DURING CESAREAN DELIVERY, the ObGyn rotated the baby from a transverse to a cephalic lie, and used a vacuum extractor to deliver the head through the hysterotomy incision.
When the child was 25 hours old, he suffered a seizure that lasted 6 minutes. Focal seizure activity involving the left side of his body and a skull fracture were identified. He was transferred to another hospital, where radiologic studies indicated a middle right cerebral artery infarct. The child developed an ongoing seizure disorder, speech and language delays, and mild, left-sided weakness.
PARENTS’ CLAIM The baby’s head was not properly delivered through the cesarean incision nor should the ObGyn have used vacuum extraction. The combination of the rotation and use of vacuum caused trauma to the infant’s head. In addition, the baby was placed in the well-baby nursery, which was inappropriate because he was born through thick meconium, resuscitated by a neonatal nurse, and had a depressed skull fracture.
PHYSICIAN’S DEFENSE Delivery was not traumatic; all treatment was appropriate.
VERDICT A $4.6 million New York settlement was reached with the hospital and ObGyn’s insurer.
Mother gets severe headache during birth
A 35-YEAR-OLD WOMAN began having a severe headache during delivery that continued after birth. She was discharged from the hospital and collapsed at home a day later. She was returned to the ED, where she was left in a hallway for 6 hours. She lost consciousness while in the hallway. Imaging and neurologic evaluation determined that she suffered a hypoxic brain injury from intracranial bleeding. She has slow response time, difficulty with all aspects of everyday life, and requires full-time attendant care.
PATIENT’S CLAIM Although she complained of a headache, no testing was done prior to her hospital discharge. Treatment was extremely delayed in the ED; an earlier diagnosis could have prevented brain damage.
PHYSICIAN’S DEFENSE Nothing could have prevented the brain damage.
VERDICT A $3.5 million California settlement was mediated.
Shoulder dystocia; brachial plexus injury
WHEN SHOULDER DYSTOCIA was encountered during delivery, the ObGyn applied gentle pressure to deliver the head. He was assisted by an ObGyn resident. The child was born with a brachial plexus injury, causing left-arm paralysis. She underwent surgery that increased her range of motion, but she will need years of physical therapy.
PATIENT’S CLAIM The ObGyn applied excessive traction and the resident improperly applied fundal pressure.
DEFENDANTS’ DEFENSE Only gentle traction was used. The resident did not apply fundal pressure.
VERDICT A New York jury found the ObGyn at fault and awarded the patient $3.5 million. The resident was vindicated.
AN EXPECTANT MOTHER MISCARRIED AT HOME at 6 months’ gestation, and an ambulance was called. After the EMTs helped the mother to the ambulance, they retrieved the fetus. When the baby was seen moving its head, the EMTs requested assistance from the advanced life support (ALS) team. ALS personnel visually assessed the fetus, determined it was nonviable, and placed the baby in a small container. The mother and baby arrived at the hospital 17 minutes after the ambulance was called.
At the hospital, a nurse noticed that the fetus was warm and had a heartbeat. The baby was taken to a special-care nursery for resuscitation and then transferred to another hospital’s NICU. The baby died after 46 days from severe brain damage due to lack of oxygen.
PARENTS’ CLAIM The EMTs and ALS team should have provided better evaluation and treatment for the infant; they were not trained to determine an infant’s viability. Placing the infant inside a plastic bag inside a box with a lid further deprived the baby of oxygen.
DEFENDANTS’ DEFENSE The case was settled before trial.
VERDICT A $1 million Massachusetts settlement was reached.
Were records altered because of a delayed diagnosis?
A WOMAN FOUND A LUMP in her left breast. A gynecologist ordered mammography. In January 2006, the radiologist requested ultrasonography (US), and reported that it conclusively indicated that the mass was a cyst. The gynecologist told the patient the tests were normal; further action was unnecessary. The patient saw the gynecologist four more times before being referred to a breast surgeon. In June 2006, she underwent surgical resection and chemotherapy for a malignant breast tumor.
PATIENT’S CLAIM The gynecologist was negligent for not referring the patient to a surgeon earlier. The gynecologist altered records: excerpts from the mammogram and US reports had been scanned in with a notation that the gynecologist had told the patient to follow up with a surgeon. When the gynecologist faxed the same reports to the surgeon, the annotations were absent. The gynecologist also changed the December 2005 chart, which referred to an US she never ordered.
PHYSICIAN’S DEFENSE The gynecologist stated that she regularly “merged” two reports into one document in her practice.
VERDICT A $700,000 Pennsylvania verdict was returned.
Excessive force or standard of care?
SHOULDER DYSTOCIA occurred during labor. The child sustained left brachial plexus palsy. At age 6, his left arm is paralyzed and smaller than the right arm. He has trouble performing normal daily tasks.
PATIENT’S CLAIM The ObGyn used excessive force by pulling on the baby’s head to complete the delivery. Standard of care required the ObGyn to take a more gentle approach to achieve delivery.
PHYSICIAN’S DEFENSE Delivery was performed appropriately, and did not deviate from standard of care.
VERDICT A $20.881 million Maryland verdict was returned, including $20 million for pain and suffering. The total award was reduced to $1,531,082 when the pain and suffering award was cut to $650,000 under the state’s statutory cap.
Preterm birth from an asymptomatic UTI?
A BABY WAS BORN AT 31 WEEKS’ gestation. The child has cerebral palsy, spastic quadriplegia, and requires assistance in all aspects of life.
PARENTS’ CLAIM Chorioamnionitis from a urinary tract infection (UTI) caused preterm birth. Urinalysis performed 7 weeks earlier indicated an infection, but the second-year resident caring for the mother failed to treat the UTI. The resident should have obtained a confirming urine culture, prescribed antibiotics, and monitored the mother more closely. The resident was poorly supervised.
DEFENDANTS’ DEFENSE Chorioamnionitis developed just before birth and could not be detected or prevented. A UTI cannot remain asymptomatic for 7 weeks and still cause premature birth. The mother was at increased risk of premature delivery because she had given birth to an anencephalic infant a year earlier. She began prenatal care in the middle of her pregnancy and ignored a referral to a high-risk maternal fetal specialist.
VERDICT A New York defense verdict was returned.
These cases were selected by the editors of OBG Management from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska (www.verdictslaska.com). The information available to the editors about the cases presented here is sometimes incomplete. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.
We want to hear from you! Tell us what you think.
These cases were selected by the editors of OBG Management from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska (www.verdictslaska.com). The information available to the editors about the cases presented here is sometimes incomplete. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.
We want to hear from you! Tell us what you think.
Hospitalists On the Move
Susan D. Hutchins, MD, has been named medical director of hospitalist services at Memorial Hermann The Woodlands Hospital in The Woodlands, Texas. Dr. Hutchins’ new responsibilities include managing nine hospitalists, two nurse practitioners, and one registered nurse as part of Memorial Hermann’s inpatient hospitalist program.
Lewis L. Low, MD, FCCM, FACP, has been promoted to senior vice president and chief medical officer of Legacy Health System in the Portland, Ore., and Vancouver, Wash., areas. Dr. Low has been commended by his colleagues for his supervision of several of Legacy’s hospitalist programs within the Portland metropolitan area.
Business Moves
Helena Regional Medical Center in Helena, Ark., began offering hospitalist services in September. Hospitalists will staff the 155-bed facility 24 hours a day in order to further the hospital’s mission of “Quality Care, Right Here.”
Inpatient Physicians of Southwest Florida (ISSF), a newly formed hospitalist group, has begun offering HM services in the Lee Memorial Health System’s Fort Myers, Fla.-area hospitals. ISSF is a collaborative between Brentwood, Tenn.-based Cogent HMG and the Hospitalist Group of Southwest Florida.
The Mauldin, S.C.-based OB Hospitalist Group has expanded its services to include the Owensboro Medical Health System’s 477-bed flagship facility in Owensboro, Ky., which serves northwestern Kentucky and southwestern Indiana.
—Michael O’Neal
Susan D. Hutchins, MD, has been named medical director of hospitalist services at Memorial Hermann The Woodlands Hospital in The Woodlands, Texas. Dr. Hutchins’ new responsibilities include managing nine hospitalists, two nurse practitioners, and one registered nurse as part of Memorial Hermann’s inpatient hospitalist program.
Lewis L. Low, MD, FCCM, FACP, has been promoted to senior vice president and chief medical officer of Legacy Health System in the Portland, Ore., and Vancouver, Wash., areas. Dr. Low has been commended by his colleagues for his supervision of several of Legacy’s hospitalist programs within the Portland metropolitan area.
Business Moves
Helena Regional Medical Center in Helena, Ark., began offering hospitalist services in September. Hospitalists will staff the 155-bed facility 24 hours a day in order to further the hospital’s mission of “Quality Care, Right Here.”
Inpatient Physicians of Southwest Florida (ISSF), a newly formed hospitalist group, has begun offering HM services in the Lee Memorial Health System’s Fort Myers, Fla.-area hospitals. ISSF is a collaborative between Brentwood, Tenn.-based Cogent HMG and the Hospitalist Group of Southwest Florida.
The Mauldin, S.C.-based OB Hospitalist Group has expanded its services to include the Owensboro Medical Health System’s 477-bed flagship facility in Owensboro, Ky., which serves northwestern Kentucky and southwestern Indiana.
—Michael O’Neal
Susan D. Hutchins, MD, has been named medical director of hospitalist services at Memorial Hermann The Woodlands Hospital in The Woodlands, Texas. Dr. Hutchins’ new responsibilities include managing nine hospitalists, two nurse practitioners, and one registered nurse as part of Memorial Hermann’s inpatient hospitalist program.
Lewis L. Low, MD, FCCM, FACP, has been promoted to senior vice president and chief medical officer of Legacy Health System in the Portland, Ore., and Vancouver, Wash., areas. Dr. Low has been commended by his colleagues for his supervision of several of Legacy’s hospitalist programs within the Portland metropolitan area.
Business Moves
Helena Regional Medical Center in Helena, Ark., began offering hospitalist services in September. Hospitalists will staff the 155-bed facility 24 hours a day in order to further the hospital’s mission of “Quality Care, Right Here.”
Inpatient Physicians of Southwest Florida (ISSF), a newly formed hospitalist group, has begun offering HM services in the Lee Memorial Health System’s Fort Myers, Fla.-area hospitals. ISSF is a collaborative between Brentwood, Tenn.-based Cogent HMG and the Hospitalist Group of Southwest Florida.
The Mauldin, S.C.-based OB Hospitalist Group has expanded its services to include the Owensboro Medical Health System’s 477-bed flagship facility in Owensboro, Ky., which serves northwestern Kentucky and southwestern Indiana.
—Michael O’Neal
Contracts Need to Ensure Physicians are Free Agents
Physicians often have medical interests other than clinical practice. A restrictive employment agreement could quash those endeavors. Physician employment agreements play an integral role in establishing the legal, financial, and operational structure of the relationship between employer and physician/employee.
One clause of particular interest to many physicians is the clause defining what a physician can and cannot do outside of providing medical services on behalf of their employer—meaning, can the physician engage in such outside activities as moonlighting, volunteering, or serving as an expert witness? Moreover, if income is generated from these outside activities, who does that income belong to—the physician or the employer?
These questions should be clearly answered in the employment agreement. And if the answers in the employment agreement do not mirror the physician’s wishes, then these terms should be negotiated with the employer and memorialized in the employment agreement.
Consult Your Contract
The first question is whether the physician is even permitted under their employment agreement to participate in activities or perform services outside of employment. Some employers prohibit engagement in outside activities and services altogether, while other employers permit certain activities that do not interfere with the physician’s day-to-day responsibilities. Physicians should be aware of requirements that give the employer the right to approve or reject outside activities. If the physician wants to be able to engage in moonlighting, expert witness consultations and testimony, speaking opportunities, volunteer efforts, teaching, research, or publishing, the physician’s desired activities should be specifically identified in the employment agreement as permitted activities.
For example: Dr. A was joining a medical practice and was presented with the group’s template employment agreement. The draft agreement precluded Dr. A from participating in any medically related outside activities. In the past, Dr. A had served as a volunteer doctor for the local marathon, a medical expert witness, and was a frequent paid speaker at conferences. For Dr. A, a prohibition on outside medical activities did not align with his interests. With minimal discussion, the practice permitted Dr. A to identify the outside activities that he could conduct without violating his employment agreement:
If a physician is permitted to engage in outside activities or services, the second question is whether income generated from such activities belongs to the physician or the employer. This often is a topic of negotiation. Physician and employer frequently do not see eye to eye on this issue. Physicians, on the one hand, often view the income generated from permitted outside activities to be separate and apart from his or her services on behalf of the employer, and thus are outside the reach of the practice. This position is strengthened if the activity occurs on the physician’s own time and outside of the employer’s hours of operation. Employers, on the other hand, often view income from outside activities as part of the employment relationship with the physician. Some employers are of the belief that the physician would not have had the opportunity to participate in the outside activity but for the physician’s employment with the particular employer.
Dr. A’s employer felt that it already was conceding by allowing Dr. A to engage in outside activities and insisted that any payment received by him for these services should be remitted to the practice. Dr. A agreed to this and negotiated for the outside activity monies to be included in his collection amounts, which was a factor in calculating Dr. A’s compensation:
The last question is whether outside activities are covered by the physician’s malpractice insurance policy. If the employer provides the policy for the benefit of the physician, the employer—and the malpractice insurance carrier—may exclude activities performed by the physician outside of his or her employment with that employer. This often is an issue for physicians who want to moonlight, as moonlighting for a third party frequently is excluded from coverage. It is important that the physician consult the malpractice insurance carrier to confirm whether certain activities are covered under the policy. It may be the case that a separate policy is required to insure the physician’s outside activities, even those activities that are unpaid.
Contract clauses describing what the physician can and cannot do outside of the employment relationship are of key importance. These clauses should mirror the individual physician’s medically related and extracurricular interests, and the financial benefits of these activities—if any—should be addressed in the employment agreement. Don’t forget to check with the insurance carrier to ensure that the activity is covered by the policy, as even volunteering medical services could expose a physician. It is best to address these issues at the onset of the employer-employee relationship. That way, all parties are on the same page from the beginning.
Steven Harris is a nationally recognized healthcare attorney and a member of the law firm McDonald Hopkins LLC in Chicago. Write to him at [email protected].
Physicians often have medical interests other than clinical practice. A restrictive employment agreement could quash those endeavors. Physician employment agreements play an integral role in establishing the legal, financial, and operational structure of the relationship between employer and physician/employee.
One clause of particular interest to many physicians is the clause defining what a physician can and cannot do outside of providing medical services on behalf of their employer—meaning, can the physician engage in such outside activities as moonlighting, volunteering, or serving as an expert witness? Moreover, if income is generated from these outside activities, who does that income belong to—the physician or the employer?
These questions should be clearly answered in the employment agreement. And if the answers in the employment agreement do not mirror the physician’s wishes, then these terms should be negotiated with the employer and memorialized in the employment agreement.
Consult Your Contract
The first question is whether the physician is even permitted under their employment agreement to participate in activities or perform services outside of employment. Some employers prohibit engagement in outside activities and services altogether, while other employers permit certain activities that do not interfere with the physician’s day-to-day responsibilities. Physicians should be aware of requirements that give the employer the right to approve or reject outside activities. If the physician wants to be able to engage in moonlighting, expert witness consultations and testimony, speaking opportunities, volunteer efforts, teaching, research, or publishing, the physician’s desired activities should be specifically identified in the employment agreement as permitted activities.
For example: Dr. A was joining a medical practice and was presented with the group’s template employment agreement. The draft agreement precluded Dr. A from participating in any medically related outside activities. In the past, Dr. A had served as a volunteer doctor for the local marathon, a medical expert witness, and was a frequent paid speaker at conferences. For Dr. A, a prohibition on outside medical activities did not align with his interests. With minimal discussion, the practice permitted Dr. A to identify the outside activities that he could conduct without violating his employment agreement:
If a physician is permitted to engage in outside activities or services, the second question is whether income generated from such activities belongs to the physician or the employer. This often is a topic of negotiation. Physician and employer frequently do not see eye to eye on this issue. Physicians, on the one hand, often view the income generated from permitted outside activities to be separate and apart from his or her services on behalf of the employer, and thus are outside the reach of the practice. This position is strengthened if the activity occurs on the physician’s own time and outside of the employer’s hours of operation. Employers, on the other hand, often view income from outside activities as part of the employment relationship with the physician. Some employers are of the belief that the physician would not have had the opportunity to participate in the outside activity but for the physician’s employment with the particular employer.
Dr. A’s employer felt that it already was conceding by allowing Dr. A to engage in outside activities and insisted that any payment received by him for these services should be remitted to the practice. Dr. A agreed to this and negotiated for the outside activity monies to be included in his collection amounts, which was a factor in calculating Dr. A’s compensation:
The last question is whether outside activities are covered by the physician’s malpractice insurance policy. If the employer provides the policy for the benefit of the physician, the employer—and the malpractice insurance carrier—may exclude activities performed by the physician outside of his or her employment with that employer. This often is an issue for physicians who want to moonlight, as moonlighting for a third party frequently is excluded from coverage. It is important that the physician consult the malpractice insurance carrier to confirm whether certain activities are covered under the policy. It may be the case that a separate policy is required to insure the physician’s outside activities, even those activities that are unpaid.
Contract clauses describing what the physician can and cannot do outside of the employment relationship are of key importance. These clauses should mirror the individual physician’s medically related and extracurricular interests, and the financial benefits of these activities—if any—should be addressed in the employment agreement. Don’t forget to check with the insurance carrier to ensure that the activity is covered by the policy, as even volunteering medical services could expose a physician. It is best to address these issues at the onset of the employer-employee relationship. That way, all parties are on the same page from the beginning.
Steven Harris is a nationally recognized healthcare attorney and a member of the law firm McDonald Hopkins LLC in Chicago. Write to him at [email protected].
Physicians often have medical interests other than clinical practice. A restrictive employment agreement could quash those endeavors. Physician employment agreements play an integral role in establishing the legal, financial, and operational structure of the relationship between employer and physician/employee.
One clause of particular interest to many physicians is the clause defining what a physician can and cannot do outside of providing medical services on behalf of their employer—meaning, can the physician engage in such outside activities as moonlighting, volunteering, or serving as an expert witness? Moreover, if income is generated from these outside activities, who does that income belong to—the physician or the employer?
These questions should be clearly answered in the employment agreement. And if the answers in the employment agreement do not mirror the physician’s wishes, then these terms should be negotiated with the employer and memorialized in the employment agreement.
Consult Your Contract
The first question is whether the physician is even permitted under their employment agreement to participate in activities or perform services outside of employment. Some employers prohibit engagement in outside activities and services altogether, while other employers permit certain activities that do not interfere with the physician’s day-to-day responsibilities. Physicians should be aware of requirements that give the employer the right to approve or reject outside activities. If the physician wants to be able to engage in moonlighting, expert witness consultations and testimony, speaking opportunities, volunteer efforts, teaching, research, or publishing, the physician’s desired activities should be specifically identified in the employment agreement as permitted activities.
For example: Dr. A was joining a medical practice and was presented with the group’s template employment agreement. The draft agreement precluded Dr. A from participating in any medically related outside activities. In the past, Dr. A had served as a volunteer doctor for the local marathon, a medical expert witness, and was a frequent paid speaker at conferences. For Dr. A, a prohibition on outside medical activities did not align with his interests. With minimal discussion, the practice permitted Dr. A to identify the outside activities that he could conduct without violating his employment agreement:
If a physician is permitted to engage in outside activities or services, the second question is whether income generated from such activities belongs to the physician or the employer. This often is a topic of negotiation. Physician and employer frequently do not see eye to eye on this issue. Physicians, on the one hand, often view the income generated from permitted outside activities to be separate and apart from his or her services on behalf of the employer, and thus are outside the reach of the practice. This position is strengthened if the activity occurs on the physician’s own time and outside of the employer’s hours of operation. Employers, on the other hand, often view income from outside activities as part of the employment relationship with the physician. Some employers are of the belief that the physician would not have had the opportunity to participate in the outside activity but for the physician’s employment with the particular employer.
Dr. A’s employer felt that it already was conceding by allowing Dr. A to engage in outside activities and insisted that any payment received by him for these services should be remitted to the practice. Dr. A agreed to this and negotiated for the outside activity monies to be included in his collection amounts, which was a factor in calculating Dr. A’s compensation:
The last question is whether outside activities are covered by the physician’s malpractice insurance policy. If the employer provides the policy for the benefit of the physician, the employer—and the malpractice insurance carrier—may exclude activities performed by the physician outside of his or her employment with that employer. This often is an issue for physicians who want to moonlight, as moonlighting for a third party frequently is excluded from coverage. It is important that the physician consult the malpractice insurance carrier to confirm whether certain activities are covered under the policy. It may be the case that a separate policy is required to insure the physician’s outside activities, even those activities that are unpaid.
Contract clauses describing what the physician can and cannot do outside of the employment relationship are of key importance. These clauses should mirror the individual physician’s medically related and extracurricular interests, and the financial benefits of these activities—if any—should be addressed in the employment agreement. Don’t forget to check with the insurance carrier to ensure that the activity is covered by the policy, as even volunteering medical services could expose a physician. It is best to address these issues at the onset of the employer-employee relationship. That way, all parties are on the same page from the beginning.
Steven Harris is a nationally recognized healthcare attorney and a member of the law firm McDonald Hopkins LLC in Chicago. Write to him at [email protected].
Surgical Drain Removed But Not Replaced
Seventeen months after undergoing unsuccessful back fusion surgery, a Utah man underwent a repeat procedure, performed by the defendant surgeon. The patient alleged that a surgical technician removed a Hemovac® drain from the incision site as the surgical drapes were removed following the procedure. The drain was allegedly not replaced before the patient was taken to the recovery area.
He complained of numbness and inability to move his legs. The surgeon was notified and advised the hospital staff to continue monitoring the patient. When the problems persisted, he was returned to surgery. The surgeon found a large hematoma and removed several hundred cc’s of blood.
Since then, the patient has had continuing problems despite treatment with steroids and physical therapy, and following a 10-month stay in a skilled nursing facility. The patient is essentially paralyzed from the waist down and confined for the most part to a wheelchair.
The plaintiff alleged that he was not a suitable candidate for the second back fusion in light of his previous unsuccessful surgery. The plaintiff also claimed that removal of the drain allowed the hematoma to develop, causing compression and damage to the spinal nerves.
OUTCOME
According to a published account, a confidential settlement was reached with the hospital. Claims against the surgeon and a PA were pending.
COMMENT
It is important for every member of the surgical team to know the number and location of surgical drains and to monitor drainage output. Here, removal of a drain resulted in the formation of a large hematoma, which caused compressive damage to the spinal nerves.
We don’t know when the patient developed symptoms or how soon he was reevaluated by the surgical team. We do know there was a delay between the patient’s first report of symptoms and the operation to evacuate the hematoma.
The legal case names the hospital, the physician, and a PA as defendants. The hospital has liability for the actions of the surgical technician, provided this employee is generally operating within the scope of his or her employment.
The confidential settlement with the hospital permits the plaintiff to recover against the hospital for the technician’s removal of the drain, while pursuing different claims against the surgeon and the PA. Presumptively, these breaches in the standard of care against the clinicians would be a failure to supervise the clinical staff, failure to anchor the drain (perhaps), failure to adequately monitor the patient postoperatively, and failure to act on the patient’s deteriorating status in a timely fashion.
Under the best circumstances, jurors expect surgeons to make a personal appearance shortly after surgery. In the case of complications, jurors expect an immediate and reassuring presence. It may be impossible for the surgeon to visit the patient’s bedside immediately—making communication between the surgical team and the surgical nursing staff imperative.
Essentially, this patient has lost the use of his legs and is wheelchair dependent, making substantial damages possible. The case will turn on whether the jurors believe the surgeon and the PA were adequately responsive to the patient’s condition. They will likely consider factors such as the time interval between the patient’s first complaint and the operation to evacuate the hematoma, and the communication between the surgical team and the surgical nurses, to determine whether the clinicians were appropriately responsive. In sum, surgical clinicians should have well-oiled mechanisms in place to manage low-risk, expected complications, and to investigate atypical or serious complications quickly and personally. —DML
Cases reprinted with permission from Medical Malpractice Verdicts, Settlements and Experts, Lewis Laska, Editor, (800) 298-6288.
Seventeen months after undergoing unsuccessful back fusion surgery, a Utah man underwent a repeat procedure, performed by the defendant surgeon. The patient alleged that a surgical technician removed a Hemovac® drain from the incision site as the surgical drapes were removed following the procedure. The drain was allegedly not replaced before the patient was taken to the recovery area.
He complained of numbness and inability to move his legs. The surgeon was notified and advised the hospital staff to continue monitoring the patient. When the problems persisted, he was returned to surgery. The surgeon found a large hematoma and removed several hundred cc’s of blood.
Since then, the patient has had continuing problems despite treatment with steroids and physical therapy, and following a 10-month stay in a skilled nursing facility. The patient is essentially paralyzed from the waist down and confined for the most part to a wheelchair.
The plaintiff alleged that he was not a suitable candidate for the second back fusion in light of his previous unsuccessful surgery. The plaintiff also claimed that removal of the drain allowed the hematoma to develop, causing compression and damage to the spinal nerves.
OUTCOME
According to a published account, a confidential settlement was reached with the hospital. Claims against the surgeon and a PA were pending.
COMMENT
It is important for every member of the surgical team to know the number and location of surgical drains and to monitor drainage output. Here, removal of a drain resulted in the formation of a large hematoma, which caused compressive damage to the spinal nerves.
We don’t know when the patient developed symptoms or how soon he was reevaluated by the surgical team. We do know there was a delay between the patient’s first report of symptoms and the operation to evacuate the hematoma.
The legal case names the hospital, the physician, and a PA as defendants. The hospital has liability for the actions of the surgical technician, provided this employee is generally operating within the scope of his or her employment.
The confidential settlement with the hospital permits the plaintiff to recover against the hospital for the technician’s removal of the drain, while pursuing different claims against the surgeon and the PA. Presumptively, these breaches in the standard of care against the clinicians would be a failure to supervise the clinical staff, failure to anchor the drain (perhaps), failure to adequately monitor the patient postoperatively, and failure to act on the patient’s deteriorating status in a timely fashion.
Under the best circumstances, jurors expect surgeons to make a personal appearance shortly after surgery. In the case of complications, jurors expect an immediate and reassuring presence. It may be impossible for the surgeon to visit the patient’s bedside immediately—making communication between the surgical team and the surgical nursing staff imperative.
Essentially, this patient has lost the use of his legs and is wheelchair dependent, making substantial damages possible. The case will turn on whether the jurors believe the surgeon and the PA were adequately responsive to the patient’s condition. They will likely consider factors such as the time interval between the patient’s first complaint and the operation to evacuate the hematoma, and the communication between the surgical team and the surgical nurses, to determine whether the clinicians were appropriately responsive. In sum, surgical clinicians should have well-oiled mechanisms in place to manage low-risk, expected complications, and to investigate atypical or serious complications quickly and personally. —DML
Cases reprinted with permission from Medical Malpractice Verdicts, Settlements and Experts, Lewis Laska, Editor, (800) 298-6288.
Seventeen months after undergoing unsuccessful back fusion surgery, a Utah man underwent a repeat procedure, performed by the defendant surgeon. The patient alleged that a surgical technician removed a Hemovac® drain from the incision site as the surgical drapes were removed following the procedure. The drain was allegedly not replaced before the patient was taken to the recovery area.
He complained of numbness and inability to move his legs. The surgeon was notified and advised the hospital staff to continue monitoring the patient. When the problems persisted, he was returned to surgery. The surgeon found a large hematoma and removed several hundred cc’s of blood.
Since then, the patient has had continuing problems despite treatment with steroids and physical therapy, and following a 10-month stay in a skilled nursing facility. The patient is essentially paralyzed from the waist down and confined for the most part to a wheelchair.
The plaintiff alleged that he was not a suitable candidate for the second back fusion in light of his previous unsuccessful surgery. The plaintiff also claimed that removal of the drain allowed the hematoma to develop, causing compression and damage to the spinal nerves.
OUTCOME
According to a published account, a confidential settlement was reached with the hospital. Claims against the surgeon and a PA were pending.
COMMENT
It is important for every member of the surgical team to know the number and location of surgical drains and to monitor drainage output. Here, removal of a drain resulted in the formation of a large hematoma, which caused compressive damage to the spinal nerves.
We don’t know when the patient developed symptoms or how soon he was reevaluated by the surgical team. We do know there was a delay between the patient’s first report of symptoms and the operation to evacuate the hematoma.
The legal case names the hospital, the physician, and a PA as defendants. The hospital has liability for the actions of the surgical technician, provided this employee is generally operating within the scope of his or her employment.
The confidential settlement with the hospital permits the plaintiff to recover against the hospital for the technician’s removal of the drain, while pursuing different claims against the surgeon and the PA. Presumptively, these breaches in the standard of care against the clinicians would be a failure to supervise the clinical staff, failure to anchor the drain (perhaps), failure to adequately monitor the patient postoperatively, and failure to act on the patient’s deteriorating status in a timely fashion.
Under the best circumstances, jurors expect surgeons to make a personal appearance shortly after surgery. In the case of complications, jurors expect an immediate and reassuring presence. It may be impossible for the surgeon to visit the patient’s bedside immediately—making communication between the surgical team and the surgical nursing staff imperative.
Essentially, this patient has lost the use of his legs and is wheelchair dependent, making substantial damages possible. The case will turn on whether the jurors believe the surgeon and the PA were adequately responsive to the patient’s condition. They will likely consider factors such as the time interval between the patient’s first complaint and the operation to evacuate the hematoma, and the communication between the surgical team and the surgical nurses, to determine whether the clinicians were appropriately responsive. In sum, surgical clinicians should have well-oiled mechanisms in place to manage low-risk, expected complications, and to investigate atypical or serious complications quickly and personally. —DML
Cases reprinted with permission from Medical Malpractice Verdicts, Settlements and Experts, Lewis Laska, Editor, (800) 298-6288.
Undiluted Acetic Acid Used for Surgery on Vulvar Lesion
Cases reprinted with permission from Medical Malpractice Verdicts, Settlements and Experts, Lewis Laska, Editor, (800) 298-6288.
Undiluted Acetic Acid Used for Surgery on Vulvar Lesion
The patient, a 42-year-old Ohio woman, was scheduled for a
gynecologic surgical procedure. The surgery was to be performed in the hospital by a general practice obstetrician/gynecologist for treatment of low-grade squamous intraepithelial lesions (ie, vulvar intraepithelial neoplasm [VIN] with moderate dysplasia). The planned procedure was a wide local excision of the vulvar lesions, to be performed under general anesthesia.
The procedure typically includes application of a diluted acetic acid wash to the vulvar area to delineate the borders of the dysplastic areas. Instead of the diluted solution, however, a highly concentrated acetic acid, trichloroacetic acid (TCA), was used.
The patient sustained a severe chemical burn of the vulva, which took several months to heal. She was left with permanent scarring of the vulvar area and extreme tenderness at the vaginal opening, which is atrophic and severely reddened and discolored. The patient has a band of thick scar tissue at the posterior fourchette, and she also sustained burning and severe scarring of the perineum that extends to the anal area, including a 2-mm plaque layer.
The plaintiff claimed that her injuries limited her to extremely painful sexual intercourse (if any), as well as discomfort at all times. Only a complicated set of additional surgical procedures could be recommended to attempt to alleviate her condition and allow relatively pain-free intercourse.
OUTCOME
A $600,000 settlement was reached in direct negotiations with the risk management department of the hospital in question.
COMMENT
This case settled before trial after direct negotiations with the hospital’s risk management department, which is unusual; cases are typically turned over to trial counsel after a case is initiated.
Jurors take a harsh view of such mix-ups, expecting simple safety precautions, like clear labeling, to prevent devastating outcomes.
The negotiated settlement is rather low, given the patient’s pain and demonstrable losses. Ohio has a damages cap on noneconomic damages (eg, pain and suffering, vs economic damages, such as loss of income). Ohio also has a cap on punitive damages—which is double the cap on compensatory damages. In a different jurisdiction without these caps, the defendant hospital’s exposure to larger damages would have been greater.
Clinicians must take an active role to prevent such outcomes. Any substance used in a clinical setting should be clearly labeled. Items not suitable for direct patient use (eg, undiluted acetic acid) should never be brought into the examining room or the operating room. Clinicians should actively monitor support personnel to detect practices that could result in an accident.
Our role as clinicians is to protect the patient: That includes monitoring our practice environment for patterns that could result in accidents (eg, slip and fall), errors (medication administered to the incorrect patient), or unclear accountability (lab values not reviewed in a timely manner). Stay vigilant and work within your team practice environment to spot and correct problems before those problems ripen into errors that may injure patients and land clinicians in court. —DML
Excessive Epinephrine Injection Causes Cardiac Arrest
An Idaho woman, age 39, was to undergo an arthroscopic shoulder procedure in February 2007 at a specialty hospital. Prior to surgery, the patient was mistakenly given an injection of 9 cc epinephrine at a concentration of 1:1,000 instead of the ordered presurgical injection—a diluted concentration of epinephrine 1:200,000, combined with bupivacaine. The patient went into full cardiac arrest and was subsequently diagnosed with a mild brain injury resulting from the lengthy code conducted at the hospital.
The plaintiff claimed that the hospital’s use of 30-mL multidose vials of concentrated epinephrine 1:1,000 in the operating room heightened the risk for medication error. The plaintiff also claimed that the circulating nurse failed to properly label the syringe containing the medication and that the circulating nurse failed to properly run a time-out procedure prior to the medication error.
The defendant claimed that the presence of multidose vials of concentrated epinephrine in the operating room was proper and that the syringe used to inject the plaintiff was properly labeled. The defendant also claimed that a time-out had been properly conducted prior to the medication error.
OUTCOME
According to a published account, a $760,000 verdict was returned. The plaintiff had settled the claim against the orthopedic group prior to trial for a confidential amount and had entered into a high-low agreement with the hospital ($750,000/$500,000) minutes before the verdict was returned.
COMMENT
As in the previous case, this action involves the unintended use of a substance (epinephrine 1:1,000) that bears some similarity to the correct substance (bupivacaine with epinephrine 1:200,000). There was disagreement as to whether the syringe was properly labeled.
Here, the case was settled against the orthopedic surgeon. The hospital has vicarious liability for the circulating nurse as an employee of the hospital. The plaintiff alleged that the use of the multidose vial was risky, and that the nurse did not perform an adequate time-out procedure before the error. This procedure is designed to give nurses protected time, free from other distractions, within which to manage and administer medications. The concept of protected time seeks to minimize errors of medication administration by giving nurses dedicated time to concentrate only on medications without the usual distractions from clinicians, other patients, telephone calls, pages, and the like. This is important, because a clinician’s prescribing or ordering error is often detected (by pharmacists or nurses, respectively). Generally, when a nurse administers a medication, there is no automatic “second pair of eyes” to review his or her action.
In this instance, however, the opposite situation existed: The nurse prepared the medication, and the physician administered it. The plaintiff’s contention was that the nurse mislabeled the medication, and the plaintiff was able to prevail at trial on this theory.
Interestingly, the plaintiff likely took the opposite position with the physician to obtain settlement before trial—that is, that the nurse correctly labeled the syringe, but it was inappropriately administered by the physician. After settling with the physician, the plaintiff was free to change the theory of the case—placing blame with the nurse and hospital. At trial, with an injured plaintiff and no clinician to blame, the jury found the plaintiff’s position credible and found the nurse responsible.
If there was no indication for 9 mL of epinephrine 1:1,000 to be placed on a tray next to bupivacaine with epinephrine 1:200,000, the jury would believe the medication was mislabeled. While epinephrine is often used to increase visualization during arthroscopic surgery, it is typically added to the irrigation solution (eg, 1 mL epinephrine 1:1,000 added to 3,000 mL of irrigation fluid). From the facts given, it is unclear whether the undiluted epinephrine 1:1,000 was kept within the surgeon’s reach. If so, this was a dangerous practice pattern that could have been recognized and the outcome prevented.
Confusion can lead to use of an incorrect concentration of the correct medication. This is particularly true with epinephrine—a substance with a built-in, tenfold fatal error potential. Epinephrine 1:1,000 (generally used for subcutaneous administration) can have disastrous consequences when given in place of epinephrine 1:10,000 (generally administered by IV). Several fatal and near-fatal cases have been reported involving this error. Epinephrine 1:1,000 in 30-mL vials has been specified for its overdose potential. Consider replacing these vials with 1-mL ampoules, and if this is not feasible, consider applying a warning label: “not for IV use without appropriate dilution.”
In cases in which similar medications are used in close proximity, consider applying a use-based label in addition to that showing dosing/concentration. For example, try labeling the syringe of epinephrine 1:1,000 “for subcutaneous/endotracheal use only” versus epinephrine 1:10,000, “for intravenous use.”
In whatever setting you practice, do your part to ensure that staff is specifically alerted to the hazard of potentially fatal epinephrine concentration errors. A life saved by preventing an error is a life saved. —DML
Cases reprinted with permission from Medical Malpractice Verdicts, Settlements and Experts, Lewis Laska, Editor, (800) 298-6288.
Undiluted Acetic Acid Used for Surgery on Vulvar Lesion
The patient, a 42-year-old Ohio woman, was scheduled for a
gynecologic surgical procedure. The surgery was to be performed in the hospital by a general practice obstetrician/gynecologist for treatment of low-grade squamous intraepithelial lesions (ie, vulvar intraepithelial neoplasm [VIN] with moderate dysplasia). The planned procedure was a wide local excision of the vulvar lesions, to be performed under general anesthesia.
The procedure typically includes application of a diluted acetic acid wash to the vulvar area to delineate the borders of the dysplastic areas. Instead of the diluted solution, however, a highly concentrated acetic acid, trichloroacetic acid (TCA), was used.
The patient sustained a severe chemical burn of the vulva, which took several months to heal. She was left with permanent scarring of the vulvar area and extreme tenderness at the vaginal opening, which is atrophic and severely reddened and discolored. The patient has a band of thick scar tissue at the posterior fourchette, and she also sustained burning and severe scarring of the perineum that extends to the anal area, including a 2-mm plaque layer.
The plaintiff claimed that her injuries limited her to extremely painful sexual intercourse (if any), as well as discomfort at all times. Only a complicated set of additional surgical procedures could be recommended to attempt to alleviate her condition and allow relatively pain-free intercourse.
OUTCOME
A $600,000 settlement was reached in direct negotiations with the risk management department of the hospital in question.
COMMENT
This case settled before trial after direct negotiations with the hospital’s risk management department, which is unusual; cases are typically turned over to trial counsel after a case is initiated.
Jurors take a harsh view of such mix-ups, expecting simple safety precautions, like clear labeling, to prevent devastating outcomes.
The negotiated settlement is rather low, given the patient’s pain and demonstrable losses. Ohio has a damages cap on noneconomic damages (eg, pain and suffering, vs economic damages, such as loss of income). Ohio also has a cap on punitive damages—which is double the cap on compensatory damages. In a different jurisdiction without these caps, the defendant hospital’s exposure to larger damages would have been greater.
Clinicians must take an active role to prevent such outcomes. Any substance used in a clinical setting should be clearly labeled. Items not suitable for direct patient use (eg, undiluted acetic acid) should never be brought into the examining room or the operating room. Clinicians should actively monitor support personnel to detect practices that could result in an accident.
Our role as clinicians is to protect the patient: That includes monitoring our practice environment for patterns that could result in accidents (eg, slip and fall), errors (medication administered to the incorrect patient), or unclear accountability (lab values not reviewed in a timely manner). Stay vigilant and work within your team practice environment to spot and correct problems before those problems ripen into errors that may injure patients and land clinicians in court. —DML
Excessive Epinephrine Injection Causes Cardiac Arrest
An Idaho woman, age 39, was to undergo an arthroscopic shoulder procedure in February 2007 at a specialty hospital. Prior to surgery, the patient was mistakenly given an injection of 9 cc epinephrine at a concentration of 1:1,000 instead of the ordered presurgical injection—a diluted concentration of epinephrine 1:200,000, combined with bupivacaine. The patient went into full cardiac arrest and was subsequently diagnosed with a mild brain injury resulting from the lengthy code conducted at the hospital.
The plaintiff claimed that the hospital’s use of 30-mL multidose vials of concentrated epinephrine 1:1,000 in the operating room heightened the risk for medication error. The plaintiff also claimed that the circulating nurse failed to properly label the syringe containing the medication and that the circulating nurse failed to properly run a time-out procedure prior to the medication error.
The defendant claimed that the presence of multidose vials of concentrated epinephrine in the operating room was proper and that the syringe used to inject the plaintiff was properly labeled. The defendant also claimed that a time-out had been properly conducted prior to the medication error.
OUTCOME
According to a published account, a $760,000 verdict was returned. The plaintiff had settled the claim against the orthopedic group prior to trial for a confidential amount and had entered into a high-low agreement with the hospital ($750,000/$500,000) minutes before the verdict was returned.
COMMENT
As in the previous case, this action involves the unintended use of a substance (epinephrine 1:1,000) that bears some similarity to the correct substance (bupivacaine with epinephrine 1:200,000). There was disagreement as to whether the syringe was properly labeled.
Here, the case was settled against the orthopedic surgeon. The hospital has vicarious liability for the circulating nurse as an employee of the hospital. The plaintiff alleged that the use of the multidose vial was risky, and that the nurse did not perform an adequate time-out procedure before the error. This procedure is designed to give nurses protected time, free from other distractions, within which to manage and administer medications. The concept of protected time seeks to minimize errors of medication administration by giving nurses dedicated time to concentrate only on medications without the usual distractions from clinicians, other patients, telephone calls, pages, and the like. This is important, because a clinician’s prescribing or ordering error is often detected (by pharmacists or nurses, respectively). Generally, when a nurse administers a medication, there is no automatic “second pair of eyes” to review his or her action.
In this instance, however, the opposite situation existed: The nurse prepared the medication, and the physician administered it. The plaintiff’s contention was that the nurse mislabeled the medication, and the plaintiff was able to prevail at trial on this theory.
Interestingly, the plaintiff likely took the opposite position with the physician to obtain settlement before trial—that is, that the nurse correctly labeled the syringe, but it was inappropriately administered by the physician. After settling with the physician, the plaintiff was free to change the theory of the case—placing blame with the nurse and hospital. At trial, with an injured plaintiff and no clinician to blame, the jury found the plaintiff’s position credible and found the nurse responsible.
If there was no indication for 9 mL of epinephrine 1:1,000 to be placed on a tray next to bupivacaine with epinephrine 1:200,000, the jury would believe the medication was mislabeled. While epinephrine is often used to increase visualization during arthroscopic surgery, it is typically added to the irrigation solution (eg, 1 mL epinephrine 1:1,000 added to 3,000 mL of irrigation fluid). From the facts given, it is unclear whether the undiluted epinephrine 1:1,000 was kept within the surgeon’s reach. If so, this was a dangerous practice pattern that could have been recognized and the outcome prevented.
Confusion can lead to use of an incorrect concentration of the correct medication. This is particularly true with epinephrine—a substance with a built-in, tenfold fatal error potential. Epinephrine 1:1,000 (generally used for subcutaneous administration) can have disastrous consequences when given in place of epinephrine 1:10,000 (generally administered by IV). Several fatal and near-fatal cases have been reported involving this error. Epinephrine 1:1,000 in 30-mL vials has been specified for its overdose potential. Consider replacing these vials with 1-mL ampoules, and if this is not feasible, consider applying a warning label: “not for IV use without appropriate dilution.”
In cases in which similar medications are used in close proximity, consider applying a use-based label in addition to that showing dosing/concentration. For example, try labeling the syringe of epinephrine 1:1,000 “for subcutaneous/endotracheal use only” versus epinephrine 1:10,000, “for intravenous use.”
In whatever setting you practice, do your part to ensure that staff is specifically alerted to the hazard of potentially fatal epinephrine concentration errors. A life saved by preventing an error is a life saved. —DML
Cases reprinted with permission from Medical Malpractice Verdicts, Settlements and Experts, Lewis Laska, Editor, (800) 298-6288.
Undiluted Acetic Acid Used for Surgery on Vulvar Lesion
The patient, a 42-year-old Ohio woman, was scheduled for a
gynecologic surgical procedure. The surgery was to be performed in the hospital by a general practice obstetrician/gynecologist for treatment of low-grade squamous intraepithelial lesions (ie, vulvar intraepithelial neoplasm [VIN] with moderate dysplasia). The planned procedure was a wide local excision of the vulvar lesions, to be performed under general anesthesia.
The procedure typically includes application of a diluted acetic acid wash to the vulvar area to delineate the borders of the dysplastic areas. Instead of the diluted solution, however, a highly concentrated acetic acid, trichloroacetic acid (TCA), was used.
The patient sustained a severe chemical burn of the vulva, which took several months to heal. She was left with permanent scarring of the vulvar area and extreme tenderness at the vaginal opening, which is atrophic and severely reddened and discolored. The patient has a band of thick scar tissue at the posterior fourchette, and she also sustained burning and severe scarring of the perineum that extends to the anal area, including a 2-mm plaque layer.
The plaintiff claimed that her injuries limited her to extremely painful sexual intercourse (if any), as well as discomfort at all times. Only a complicated set of additional surgical procedures could be recommended to attempt to alleviate her condition and allow relatively pain-free intercourse.
OUTCOME
A $600,000 settlement was reached in direct negotiations with the risk management department of the hospital in question.
COMMENT
This case settled before trial after direct negotiations with the hospital’s risk management department, which is unusual; cases are typically turned over to trial counsel after a case is initiated.
Jurors take a harsh view of such mix-ups, expecting simple safety precautions, like clear labeling, to prevent devastating outcomes.
The negotiated settlement is rather low, given the patient’s pain and demonstrable losses. Ohio has a damages cap on noneconomic damages (eg, pain and suffering, vs economic damages, such as loss of income). Ohio also has a cap on punitive damages—which is double the cap on compensatory damages. In a different jurisdiction without these caps, the defendant hospital’s exposure to larger damages would have been greater.
Clinicians must take an active role to prevent such outcomes. Any substance used in a clinical setting should be clearly labeled. Items not suitable for direct patient use (eg, undiluted acetic acid) should never be brought into the examining room or the operating room. Clinicians should actively monitor support personnel to detect practices that could result in an accident.
Our role as clinicians is to protect the patient: That includes monitoring our practice environment for patterns that could result in accidents (eg, slip and fall), errors (medication administered to the incorrect patient), or unclear accountability (lab values not reviewed in a timely manner). Stay vigilant and work within your team practice environment to spot and correct problems before those problems ripen into errors that may injure patients and land clinicians in court. —DML
Excessive Epinephrine Injection Causes Cardiac Arrest
An Idaho woman, age 39, was to undergo an arthroscopic shoulder procedure in February 2007 at a specialty hospital. Prior to surgery, the patient was mistakenly given an injection of 9 cc epinephrine at a concentration of 1:1,000 instead of the ordered presurgical injection—a diluted concentration of epinephrine 1:200,000, combined with bupivacaine. The patient went into full cardiac arrest and was subsequently diagnosed with a mild brain injury resulting from the lengthy code conducted at the hospital.
The plaintiff claimed that the hospital’s use of 30-mL multidose vials of concentrated epinephrine 1:1,000 in the operating room heightened the risk for medication error. The plaintiff also claimed that the circulating nurse failed to properly label the syringe containing the medication and that the circulating nurse failed to properly run a time-out procedure prior to the medication error.
The defendant claimed that the presence of multidose vials of concentrated epinephrine in the operating room was proper and that the syringe used to inject the plaintiff was properly labeled. The defendant also claimed that a time-out had been properly conducted prior to the medication error.
OUTCOME
According to a published account, a $760,000 verdict was returned. The plaintiff had settled the claim against the orthopedic group prior to trial for a confidential amount and had entered into a high-low agreement with the hospital ($750,000/$500,000) minutes before the verdict was returned.
COMMENT
As in the previous case, this action involves the unintended use of a substance (epinephrine 1:1,000) that bears some similarity to the correct substance (bupivacaine with epinephrine 1:200,000). There was disagreement as to whether the syringe was properly labeled.
Here, the case was settled against the orthopedic surgeon. The hospital has vicarious liability for the circulating nurse as an employee of the hospital. The plaintiff alleged that the use of the multidose vial was risky, and that the nurse did not perform an adequate time-out procedure before the error. This procedure is designed to give nurses protected time, free from other distractions, within which to manage and administer medications. The concept of protected time seeks to minimize errors of medication administration by giving nurses dedicated time to concentrate only on medications without the usual distractions from clinicians, other patients, telephone calls, pages, and the like. This is important, because a clinician’s prescribing or ordering error is often detected (by pharmacists or nurses, respectively). Generally, when a nurse administers a medication, there is no automatic “second pair of eyes” to review his or her action.
In this instance, however, the opposite situation existed: The nurse prepared the medication, and the physician administered it. The plaintiff’s contention was that the nurse mislabeled the medication, and the plaintiff was able to prevail at trial on this theory.
Interestingly, the plaintiff likely took the opposite position with the physician to obtain settlement before trial—that is, that the nurse correctly labeled the syringe, but it was inappropriately administered by the physician. After settling with the physician, the plaintiff was free to change the theory of the case—placing blame with the nurse and hospital. At trial, with an injured plaintiff and no clinician to blame, the jury found the plaintiff’s position credible and found the nurse responsible.
If there was no indication for 9 mL of epinephrine 1:1,000 to be placed on a tray next to bupivacaine with epinephrine 1:200,000, the jury would believe the medication was mislabeled. While epinephrine is often used to increase visualization during arthroscopic surgery, it is typically added to the irrigation solution (eg, 1 mL epinephrine 1:1,000 added to 3,000 mL of irrigation fluid). From the facts given, it is unclear whether the undiluted epinephrine 1:1,000 was kept within the surgeon’s reach. If so, this was a dangerous practice pattern that could have been recognized and the outcome prevented.
Confusion can lead to use of an incorrect concentration of the correct medication. This is particularly true with epinephrine—a substance with a built-in, tenfold fatal error potential. Epinephrine 1:1,000 (generally used for subcutaneous administration) can have disastrous consequences when given in place of epinephrine 1:10,000 (generally administered by IV). Several fatal and near-fatal cases have been reported involving this error. Epinephrine 1:1,000 in 30-mL vials has been specified for its overdose potential. Consider replacing these vials with 1-mL ampoules, and if this is not feasible, consider applying a warning label: “not for IV use without appropriate dilution.”
In cases in which similar medications are used in close proximity, consider applying a use-based label in addition to that showing dosing/concentration. For example, try labeling the syringe of epinephrine 1:1,000 “for subcutaneous/endotracheal use only” versus epinephrine 1:10,000, “for intravenous use.”
In whatever setting you practice, do your part to ensure that staff is specifically alerted to the hazard of potentially fatal epinephrine concentration errors. A life saved by preventing an error is a life saved. —DML
Faulty equipment blamed for improper diagnosis: $78M verdict … and more
AT 36 WEEKS’ GESTATION, a woman went to the emergency department (ED) with abdominal pain. After ultrasonography (US), a nurse told her the fetus had died in utero, but the mother continued to feel fetal movement. The ED physician requested a second US, but it took 75 minutes for a radiology technician to arrive. This US showed a beating fetal heart with placental abruption. After cesarean delivery, the child was found to have cerebral palsy.
PATIENT’S CLAIM The first US was performed by an inexperienced technician using outdated equipment and the wrong transducer. An experienced technician with newer equipment should have been immediately available. The ED physician did not react when fetal distress was first identified.
DEFENDANTS’ DEFENSE The ED physician was told that the baby had died. Perhaps the child’s heart had started again by the time the second US was performed and a heartbeat found. The hospital denied negligence.
VERDICT A Pennsylvania jury found the ED physician not negligent; the hospital was 100% at fault. A $78.5 million verdict included $1.5 million in emotional distress to the mother, $10 million in pain and suffering for the child, $2million in lost future earnings, and the rest in future medical expenses.
Ligated ureter found after hysterectomy
A 50-YEAR-OLD WOMAN underwent laparoscopically assisted vaginal hysterectomy. She went to the ED with pain 6 days later. Imaging studies indicated a ligated ureter; a nephrostomy tube was placed. She required a nephrostomy bag for 4 months and underwent two repair operations.
PATIENT’S CLAIM The patient’s ureter was ligated and/or constricted during surgery. The gynecologist was negligent in failing to recognize and repair the injury during surgery.
PHYSICIAN’S DEFENSE The ureter was not ligated during surgery; therefore it could not have been discovered. In addition, injury to a ureter is a known risk of the procedure.
VERDICT An Arizona defense verdict was returned.
Myomectomy after cesarean; mother dies
IMMEDIATELY AFTER A WOMAN with preeclampsia had a cesarean delivery, she underwent a myomectomy. The day before discharge, her abdominal incision opened and a clear liquid drained. The day after discharge, she went to the ED with intense abdominal pain. Necrotizing fasciitis was found and debridement surgery performed. She was transferred to another hospital but died of sepsis several days later.
ESTATE’S CLAIM The infection occurred because the myomectomy was performed immediately following cesarean delivery. Prophylactic antibiotics were not prescribed before surgery. The mother was not fully informed as to the risks of concurrent operations. The ObGyns failed to recognize the infection before discharging the patient.
PHYSICIANS’ DEFENSE The patient was fully informed of the risks of surgery; it was reasonable to perform myomectomy immediately following cesarean delivery. There were no signs or symptoms of infection before discharge. Cesarean incisions open about 30% of the time—not a cause for concern. Prophylactic antibiotics for cesarean procedures are not standard of care. The patient’s infection was caused by a rapidly spreading, rare bacterium.
VERDICT A Michigan defense verdict was returned.
TOLAC to cesarean: baby has cerebral palsy
A WOMAN WANTED A TRIAL OF LABOR after a previous cesarean delivery (TOLAC). During labor, fetal distress was noted, and a cesarean delivery was performed. Uterine rupture had occurred. The baby has spastic cerebral palsy with significantly impaired neuromotor and cognitive abilities.
PARENTS’ CLAIM The hospital staff and physicians overlooked earlier fetal distress. A timelier delivery would have prevented the child’s injuries.
DEFENDANTs’ DEFENSE The hospital reached a confidential settlement. The ObGyns claimed fetal tracings were not suggestive of uterine rupture; they met the standard of care.
VERDICT A Texas defense verdict was returned.
WHEN GESTATIONAL DIABETES WAS DIAGNOSED at 33 weeks’ gestation, a family practitioner (FP) referred the mother to an ObGyn practice. Two ObGyns performed amniocentesis to check fetal lung maturity. After the procedure, fetal distress was noted, and the ObGyns instructed the FP to induce labor.
The baby suffered brain damage, had seizures, and has cerebral palsy. She was born without kidney function. By age 10, she had 2 kidney transplant operations and functions at a pre-kindergarten level.
PATIENT’S CLAIM The mother was not fully informed of the risks of and alternatives to amniocentesis. Although complications arose before amniocentesis, the test proceeded. The ObGyns were negligent in not performing cesarean delivery when fetal distress was detected.
DEFENDANTS’ DEFENSE The FP and hospital settled prior to trial. The ObGyns claimed that their care was an appropriate alternative to the actions the patient claimed should have been taken.
VERDICT Costs for the child’s care had reached $1.4 million before trial. A $9 million Virginia verdict was returned that included $7 million for the child and $2 million for the mother, but the settlement was reduced by the state cap.
Did HT cause breast cancer?
A 52-YEAR-OLD WOMAN was prescribed conjugated estrogens/medroxyprogesterone acetate (Prempro, Wyeth, Inc.) for hormone therapy by her gynecologist.
After taking the drug for 5 years, the patient developed invasive breast cancer. She underwent a lumpectomy, chemotherapy, and three reconstructive surgeries.
PATIENT’S CLAIM The manufacturer failed to warn of a woman’s risk of developing breast cancer while taking the product.
DEFENDANT’S DEFENSE Prempro alone does not cause cancer. The drug is just one of many contributing factors that may or may not increase the risk of developing breast cancer.
VERDICT A $3.75 million Connecticut verdict was returned for the patient plus $250,000 to her husband for loss of consortium.
Failure to diagnose preeclampsia—twice
AT 28 WEEKS’ GESTATION, a woman with a history of hypertension went to an ED with headache, nausea, vomiting, cramping, and ringing in her ears. After waiting 4 hours before being seen, her BP was 150/108 mm Hg and normal fetal heart tones were heard. The ED physician diagnosed otitis media and discharged her.
Later that evening, the patient returned to the ED with similar symptoms. A urine specimen showed significant proteinuria and the fetal heart rate was 158 bpm. A second ED physician diagnosed a urinary tract infection, prescribed antibiotics and pain medication, and sent her home.
A few hours later, she returned to the ED by ambulance suffering from eclamptic seizures. Her BP was 174/121 mm Hg, and no fetal heart tones were heard. She delivered a stillborn child by cesarean delivery.
PATIENT’S CLAIM The ED physicians were negligent in failing to diagnose preeclampsia at the first two visits.
PHYSICIANS’ DEFENSE The first ED physician settled for $45,000 while serving a prison sentence after conviction on two sex-abuse felonies related to his treatment of female patients at the same ED. The second ED physician denied negligence.
VERDICT A $50,000 Alabama verdict was returned for compensatory damages for the mother and $600,000 punitive damages for the stillborn child.
Inflated Foley catheter injures mother
DURING A LONG AND DIFFICULT LABOR, an ObGyn used forceps to complete delivery of a 31-year-old woman’s first child. The baby was healthy, but the mother has suffered urinary incontinence since delivery. Despite several repair operations, the condition remains.
PATIENT’S CLAIM The ObGyn was negligent in failing to remove a fully inflated Foley catheter before beginning delivery, leading to a urethral sphincter injury.
PHYSICIAN’S DEFENSE The decision regarding removal of the catheter was a matter of hospital policy. The ObGyn blamed improper catheter placement on the nurses.
VERDICT A Kentucky defense verdict was returned.
These cases were selected by the editors of OBG Management from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska (www.verdictslaska.com). The information available to the editors about the cases presented here is sometimes incomplete. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.
We want to hear from you! Tell us what you think.
AT 36 WEEKS’ GESTATION, a woman went to the emergency department (ED) with abdominal pain. After ultrasonography (US), a nurse told her the fetus had died in utero, but the mother continued to feel fetal movement. The ED physician requested a second US, but it took 75 minutes for a radiology technician to arrive. This US showed a beating fetal heart with placental abruption. After cesarean delivery, the child was found to have cerebral palsy.
PATIENT’S CLAIM The first US was performed by an inexperienced technician using outdated equipment and the wrong transducer. An experienced technician with newer equipment should have been immediately available. The ED physician did not react when fetal distress was first identified.
DEFENDANTS’ DEFENSE The ED physician was told that the baby had died. Perhaps the child’s heart had started again by the time the second US was performed and a heartbeat found. The hospital denied negligence.
VERDICT A Pennsylvania jury found the ED physician not negligent; the hospital was 100% at fault. A $78.5 million verdict included $1.5 million in emotional distress to the mother, $10 million in pain and suffering for the child, $2million in lost future earnings, and the rest in future medical expenses.
Ligated ureter found after hysterectomy
A 50-YEAR-OLD WOMAN underwent laparoscopically assisted vaginal hysterectomy. She went to the ED with pain 6 days later. Imaging studies indicated a ligated ureter; a nephrostomy tube was placed. She required a nephrostomy bag for 4 months and underwent two repair operations.
PATIENT’S CLAIM The patient’s ureter was ligated and/or constricted during surgery. The gynecologist was negligent in failing to recognize and repair the injury during surgery.
PHYSICIAN’S DEFENSE The ureter was not ligated during surgery; therefore it could not have been discovered. In addition, injury to a ureter is a known risk of the procedure.
VERDICT An Arizona defense verdict was returned.
Myomectomy after cesarean; mother dies
IMMEDIATELY AFTER A WOMAN with preeclampsia had a cesarean delivery, she underwent a myomectomy. The day before discharge, her abdominal incision opened and a clear liquid drained. The day after discharge, she went to the ED with intense abdominal pain. Necrotizing fasciitis was found and debridement surgery performed. She was transferred to another hospital but died of sepsis several days later.
ESTATE’S CLAIM The infection occurred because the myomectomy was performed immediately following cesarean delivery. Prophylactic antibiotics were not prescribed before surgery. The mother was not fully informed as to the risks of concurrent operations. The ObGyns failed to recognize the infection before discharging the patient.
PHYSICIANS’ DEFENSE The patient was fully informed of the risks of surgery; it was reasonable to perform myomectomy immediately following cesarean delivery. There were no signs or symptoms of infection before discharge. Cesarean incisions open about 30% of the time—not a cause for concern. Prophylactic antibiotics for cesarean procedures are not standard of care. The patient’s infection was caused by a rapidly spreading, rare bacterium.
VERDICT A Michigan defense verdict was returned.
TOLAC to cesarean: baby has cerebral palsy
A WOMAN WANTED A TRIAL OF LABOR after a previous cesarean delivery (TOLAC). During labor, fetal distress was noted, and a cesarean delivery was performed. Uterine rupture had occurred. The baby has spastic cerebral palsy with significantly impaired neuromotor and cognitive abilities.
PARENTS’ CLAIM The hospital staff and physicians overlooked earlier fetal distress. A timelier delivery would have prevented the child’s injuries.
DEFENDANTs’ DEFENSE The hospital reached a confidential settlement. The ObGyns claimed fetal tracings were not suggestive of uterine rupture; they met the standard of care.
VERDICT A Texas defense verdict was returned.
WHEN GESTATIONAL DIABETES WAS DIAGNOSED at 33 weeks’ gestation, a family practitioner (FP) referred the mother to an ObGyn practice. Two ObGyns performed amniocentesis to check fetal lung maturity. After the procedure, fetal distress was noted, and the ObGyns instructed the FP to induce labor.
The baby suffered brain damage, had seizures, and has cerebral palsy. She was born without kidney function. By age 10, she had 2 kidney transplant operations and functions at a pre-kindergarten level.
PATIENT’S CLAIM The mother was not fully informed of the risks of and alternatives to amniocentesis. Although complications arose before amniocentesis, the test proceeded. The ObGyns were negligent in not performing cesarean delivery when fetal distress was detected.
DEFENDANTS’ DEFENSE The FP and hospital settled prior to trial. The ObGyns claimed that their care was an appropriate alternative to the actions the patient claimed should have been taken.
VERDICT Costs for the child’s care had reached $1.4 million before trial. A $9 million Virginia verdict was returned that included $7 million for the child and $2 million for the mother, but the settlement was reduced by the state cap.
Did HT cause breast cancer?
A 52-YEAR-OLD WOMAN was prescribed conjugated estrogens/medroxyprogesterone acetate (Prempro, Wyeth, Inc.) for hormone therapy by her gynecologist.
After taking the drug for 5 years, the patient developed invasive breast cancer. She underwent a lumpectomy, chemotherapy, and three reconstructive surgeries.
PATIENT’S CLAIM The manufacturer failed to warn of a woman’s risk of developing breast cancer while taking the product.
DEFENDANT’S DEFENSE Prempro alone does not cause cancer. The drug is just one of many contributing factors that may or may not increase the risk of developing breast cancer.
VERDICT A $3.75 million Connecticut verdict was returned for the patient plus $250,000 to her husband for loss of consortium.
Failure to diagnose preeclampsia—twice
AT 28 WEEKS’ GESTATION, a woman with a history of hypertension went to an ED with headache, nausea, vomiting, cramping, and ringing in her ears. After waiting 4 hours before being seen, her BP was 150/108 mm Hg and normal fetal heart tones were heard. The ED physician diagnosed otitis media and discharged her.
Later that evening, the patient returned to the ED with similar symptoms. A urine specimen showed significant proteinuria and the fetal heart rate was 158 bpm. A second ED physician diagnosed a urinary tract infection, prescribed antibiotics and pain medication, and sent her home.
A few hours later, she returned to the ED by ambulance suffering from eclamptic seizures. Her BP was 174/121 mm Hg, and no fetal heart tones were heard. She delivered a stillborn child by cesarean delivery.
PATIENT’S CLAIM The ED physicians were negligent in failing to diagnose preeclampsia at the first two visits.
PHYSICIANS’ DEFENSE The first ED physician settled for $45,000 while serving a prison sentence after conviction on two sex-abuse felonies related to his treatment of female patients at the same ED. The second ED physician denied negligence.
VERDICT A $50,000 Alabama verdict was returned for compensatory damages for the mother and $600,000 punitive damages for the stillborn child.
Inflated Foley catheter injures mother
DURING A LONG AND DIFFICULT LABOR, an ObGyn used forceps to complete delivery of a 31-year-old woman’s first child. The baby was healthy, but the mother has suffered urinary incontinence since delivery. Despite several repair operations, the condition remains.
PATIENT’S CLAIM The ObGyn was negligent in failing to remove a fully inflated Foley catheter before beginning delivery, leading to a urethral sphincter injury.
PHYSICIAN’S DEFENSE The decision regarding removal of the catheter was a matter of hospital policy. The ObGyn blamed improper catheter placement on the nurses.
VERDICT A Kentucky defense verdict was returned.
AT 36 WEEKS’ GESTATION, a woman went to the emergency department (ED) with abdominal pain. After ultrasonography (US), a nurse told her the fetus had died in utero, but the mother continued to feel fetal movement. The ED physician requested a second US, but it took 75 minutes for a radiology technician to arrive. This US showed a beating fetal heart with placental abruption. After cesarean delivery, the child was found to have cerebral palsy.
PATIENT’S CLAIM The first US was performed by an inexperienced technician using outdated equipment and the wrong transducer. An experienced technician with newer equipment should have been immediately available. The ED physician did not react when fetal distress was first identified.
DEFENDANTS’ DEFENSE The ED physician was told that the baby had died. Perhaps the child’s heart had started again by the time the second US was performed and a heartbeat found. The hospital denied negligence.
VERDICT A Pennsylvania jury found the ED physician not negligent; the hospital was 100% at fault. A $78.5 million verdict included $1.5 million in emotional distress to the mother, $10 million in pain and suffering for the child, $2million in lost future earnings, and the rest in future medical expenses.
Ligated ureter found after hysterectomy
A 50-YEAR-OLD WOMAN underwent laparoscopically assisted vaginal hysterectomy. She went to the ED with pain 6 days later. Imaging studies indicated a ligated ureter; a nephrostomy tube was placed. She required a nephrostomy bag for 4 months and underwent two repair operations.
PATIENT’S CLAIM The patient’s ureter was ligated and/or constricted during surgery. The gynecologist was negligent in failing to recognize and repair the injury during surgery.
PHYSICIAN’S DEFENSE The ureter was not ligated during surgery; therefore it could not have been discovered. In addition, injury to a ureter is a known risk of the procedure.
VERDICT An Arizona defense verdict was returned.
Myomectomy after cesarean; mother dies
IMMEDIATELY AFTER A WOMAN with preeclampsia had a cesarean delivery, she underwent a myomectomy. The day before discharge, her abdominal incision opened and a clear liquid drained. The day after discharge, she went to the ED with intense abdominal pain. Necrotizing fasciitis was found and debridement surgery performed. She was transferred to another hospital but died of sepsis several days later.
ESTATE’S CLAIM The infection occurred because the myomectomy was performed immediately following cesarean delivery. Prophylactic antibiotics were not prescribed before surgery. The mother was not fully informed as to the risks of concurrent operations. The ObGyns failed to recognize the infection before discharging the patient.
PHYSICIANS’ DEFENSE The patient was fully informed of the risks of surgery; it was reasonable to perform myomectomy immediately following cesarean delivery. There were no signs or symptoms of infection before discharge. Cesarean incisions open about 30% of the time—not a cause for concern. Prophylactic antibiotics for cesarean procedures are not standard of care. The patient’s infection was caused by a rapidly spreading, rare bacterium.
VERDICT A Michigan defense verdict was returned.
TOLAC to cesarean: baby has cerebral palsy
A WOMAN WANTED A TRIAL OF LABOR after a previous cesarean delivery (TOLAC). During labor, fetal distress was noted, and a cesarean delivery was performed. Uterine rupture had occurred. The baby has spastic cerebral palsy with significantly impaired neuromotor and cognitive abilities.
PARENTS’ CLAIM The hospital staff and physicians overlooked earlier fetal distress. A timelier delivery would have prevented the child’s injuries.
DEFENDANTs’ DEFENSE The hospital reached a confidential settlement. The ObGyns claimed fetal tracings were not suggestive of uterine rupture; they met the standard of care.
VERDICT A Texas defense verdict was returned.
WHEN GESTATIONAL DIABETES WAS DIAGNOSED at 33 weeks’ gestation, a family practitioner (FP) referred the mother to an ObGyn practice. Two ObGyns performed amniocentesis to check fetal lung maturity. After the procedure, fetal distress was noted, and the ObGyns instructed the FP to induce labor.
The baby suffered brain damage, had seizures, and has cerebral palsy. She was born without kidney function. By age 10, she had 2 kidney transplant operations and functions at a pre-kindergarten level.
PATIENT’S CLAIM The mother was not fully informed of the risks of and alternatives to amniocentesis. Although complications arose before amniocentesis, the test proceeded. The ObGyns were negligent in not performing cesarean delivery when fetal distress was detected.
DEFENDANTS’ DEFENSE The FP and hospital settled prior to trial. The ObGyns claimed that their care was an appropriate alternative to the actions the patient claimed should have been taken.
VERDICT Costs for the child’s care had reached $1.4 million before trial. A $9 million Virginia verdict was returned that included $7 million for the child and $2 million for the mother, but the settlement was reduced by the state cap.
Did HT cause breast cancer?
A 52-YEAR-OLD WOMAN was prescribed conjugated estrogens/medroxyprogesterone acetate (Prempro, Wyeth, Inc.) for hormone therapy by her gynecologist.
After taking the drug for 5 years, the patient developed invasive breast cancer. She underwent a lumpectomy, chemotherapy, and three reconstructive surgeries.
PATIENT’S CLAIM The manufacturer failed to warn of a woman’s risk of developing breast cancer while taking the product.
DEFENDANT’S DEFENSE Prempro alone does not cause cancer. The drug is just one of many contributing factors that may or may not increase the risk of developing breast cancer.
VERDICT A $3.75 million Connecticut verdict was returned for the patient plus $250,000 to her husband for loss of consortium.
Failure to diagnose preeclampsia—twice
AT 28 WEEKS’ GESTATION, a woman with a history of hypertension went to an ED with headache, nausea, vomiting, cramping, and ringing in her ears. After waiting 4 hours before being seen, her BP was 150/108 mm Hg and normal fetal heart tones were heard. The ED physician diagnosed otitis media and discharged her.
Later that evening, the patient returned to the ED with similar symptoms. A urine specimen showed significant proteinuria and the fetal heart rate was 158 bpm. A second ED physician diagnosed a urinary tract infection, prescribed antibiotics and pain medication, and sent her home.
A few hours later, she returned to the ED by ambulance suffering from eclamptic seizures. Her BP was 174/121 mm Hg, and no fetal heart tones were heard. She delivered a stillborn child by cesarean delivery.
PATIENT’S CLAIM The ED physicians were negligent in failing to diagnose preeclampsia at the first two visits.
PHYSICIANS’ DEFENSE The first ED physician settled for $45,000 while serving a prison sentence after conviction on two sex-abuse felonies related to his treatment of female patients at the same ED. The second ED physician denied negligence.
VERDICT A $50,000 Alabama verdict was returned for compensatory damages for the mother and $600,000 punitive damages for the stillborn child.
Inflated Foley catheter injures mother
DURING A LONG AND DIFFICULT LABOR, an ObGyn used forceps to complete delivery of a 31-year-old woman’s first child. The baby was healthy, but the mother has suffered urinary incontinence since delivery. Despite several repair operations, the condition remains.
PATIENT’S CLAIM The ObGyn was negligent in failing to remove a fully inflated Foley catheter before beginning delivery, leading to a urethral sphincter injury.
PHYSICIAN’S DEFENSE The decision regarding removal of the catheter was a matter of hospital policy. The ObGyn blamed improper catheter placement on the nurses.
VERDICT A Kentucky defense verdict was returned.
These cases were selected by the editors of OBG Management from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska (www.verdictslaska.com). The information available to the editors about the cases presented here is sometimes incomplete. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.
We want to hear from you! Tell us what you think.
These cases were selected by the editors of OBG Management from Medical Malpractice Verdicts, Settlements & Experts, with permission of the editor, Lewis Laska (www.verdictslaska.com). The information available to the editors about the cases presented here is sometimes incomplete. Moreover, the cases may or may not have merit. Nevertheless, these cases represent the types of clinical situations that typically result in litigation and are meant to illustrate nationwide variation in jury verdicts and awards.
We want to hear from you! Tell us what you think.
Psychiatric advance directives: May you disregard them?
Discuss this article at www.facebook.com/CurrentPsychiatry
Dear Dr. Mossman:
My patient stopped antipsychotic medication, experienced a recurrence of paranoid schizophrenia, and now is involuntarily hospitalized. During her admission assessment, she said she had a “psychiatric advance directive.” I obtained the document, which says she refuses psychopharmacologic treatment under any circumstances. Without medication, she might take years to recover. How should I proceed?
Submitted by “Dr. Y”
Most psychiatrists who regularly practice hospital-based care know their state’s legal procedures for forcing psychotic, civilly committed patients to take medication to relieve their acute symptoms. In most jurisdictions, courts will order medication over a patient’s objection after finding that the patient lacks competence to refuse antipsychotic therapy and that the proposed treatment is in the patient’s best interest.1
But if a patient has a psychiatric advance directive (PAD) that opposes psychotropic medication, things may become complicated. To decide what to do if a patient’s PAD precludes administering a treatment you think is necessary, you should understand:
- what PADs do
- what courts have said about PADs
- what your state’s laws say about PADs
- where and when to seek legal advice.
What are advance directives?
An advance directive (or “declaration”) for health care (ADHC) is a legal document executed by a competent individual that states preferences regarding medical treatment should that individual become incapable of making or expressing decisions.2-4 An ADHC may be a “living will” that lays out instructions for specific health care situations or a “durable power of attorney” (DPOA) that designates a proxy decision maker, or it may include elements of both. In 1990, the U.S. Congress passed the Patient Self-Determination Act,5 which required health care institutions that receive Medicare or Medicaid to ask patients whether they have ADHCs and to give patients information about state laws governing ADHCs.
Modeled after medical advance directives, PADs let competent individuals declare their wishes should they need psychiatric treatment during a period of decision-making incapacity.3,4 At least 25 states have advance directive statutes specific to psychiatry.6 Depending on the state, PADs may allow individuals to assert their preferences regarding psychotropic medication, electroconvulsive therapy (ECT), alternatives to hospitalization, location and length of voluntary hospitalization, the treating psychiatrist, seclusion and restraint, emergency medications, and visitors.
Prevalence and praise
The prevalence of PADs is unknown. A 2006 survey of 1,011 psychiatric outpatients in California, Florida, Illinois, Massachusetts, and North Carolina by Swanson et al7 found only 4% to 13% of patients previously executed a PAD. However, most participants said that if given the opportunity and assistance, they would create a PAD.7
Psychiatric advocacy groups have lauded the development of PADs. For example, the National Alliance on Mental Illness’ position is that “PADs should be considered as a way to empower consumers to take a more active role in their treatment, and as a way to avoid conflicts over treatment and medication issues.”8 Proponents suggest that PADs:
- promote autonomy
- foster communication between patients and treatment providers
- increase compliance with medication
- reduce involuntary treatment and judicial involvement.4,8
Mental Health America launched My Plan, My Life: My Psychiatric Advance Directive in September 2011 to increase public awareness of the availability of PADs.9 Therefore, it is safe to assume that most psychiatrists will encounter patients with PADs.
What if a PAD blocks treatment?
What happens when an adult such as Dr. Y’s patient has a PAD that precludes effective treatment? A similar situation led to Hargrave v Vermont.10
Nancy Hargrave, a Vermont woman with schizophrenia and a history of psychiatric hospitalizations, executed a DPOA—Vermont does not have a separate statute for PADs—in which she explicitly refused “any and all anti-psychotic, neuroleptic, psychotropic, or psychoactive medications,” and ECT.10
In anticipation of situations like this, Vermont’s legislature passed Act 114, a 1998 state law that required caregivers to abide by the DPOAs of civilly committed individuals and mentally ill prisoners for 45 days.10 After this time, a court may override the advance directive and allow involuntary medication administration if a patient “ha[d] not experienced a significant clinical improvement in his or her mental state, and remain[ed] incompetent.”10
In 1999, Hargrave sued the state of Vermont and other parties in federal court, alleging that Act 114 constituted discrimination under Title II of the Americans with Disabilities Act11 because Act 114 excluded her from participating in the “services, programs, or activities of a public entity,” namely, the use of her DPOA under Vermont state law.10 The federal district court sided with Hargrave, concluding that “Act 114 was facially discriminatory against mentally disabled individuals.” One year later, the U.S. Court of Appeals for the Second Circuit affirmed the district court’s ruling.
Surprisingly, no other court has adjudicated this issue. However, in Second Circuit states—Vermont, New York, and Connecticut—DPOAs of mentally ill patients cannot be abrogated. This is an unsettling notion for many psychiatrists, because, as Paul Appelbaum, MD, explains, “Advance directives may now constitute an ironclad bulwark against future involuntary treatment with medication—except in emergencies—even for incompetent, committed patients and even when the alternative is long-term institutional care.”12 Other scholars have pointed out that giving physicians an avenue to override or disregard patients’ directives would negate their intended purpose, which is to have one’s competently expressed wishes followed when one’s decision-making capacity is compromised.6,13
Doctors’ duties
How you should respond to an involuntary patient’s PAD depends on which state you practice in. A physician’s obligation to comply with a patient’s PAD depends on state law, and most states with PAD laws provide some latitude or options if physicians believe they should not comply with a patient’s wishes.6,13Table 114-18 cites examples of statutory language regarding a physician’s duty to comply with a PAD.
A survey of 164 psychiatrists in North Carolina provides some insight into psychiatrists’ perceptions of PADs.19 After reading a hypothetical scenario about a mentally ill individual whose PAD expressed refusal of hospitalization or treatment with antipsychotics, 47% of the psychiatrists chose to override the PAD. The authors found that “PAD override was more likely among psychiatrists who worked in hospital emergency departments; those who were concerned about patients’ violence risk and lack of insight; and those who were legally defensive.”
In addition to addressing conflicts between patients’ PADs and doctors’ views about proper treatment, some state laws also contain clauses that spell out the limits of physician liability in cases of physician compliance or noncompliance with PADs. Excerpts from 2 such laws appear in Table 2.16-17
Table 1
Examples of state laws on compliance with psychiatric advance directives
State | Provider compliance |
---|---|
Kentucky14 | Providers must provide mental health treatment that complies with the instructions in an advance directive to the fullest extent possible when the instructions are within standards for mental and physical health care and permitted by state and federal law. Providers may override expressed refusals of treatment only if a court order contradicts the advance directive or an emergency endangers a patient’s life or poses a serious risk to physical health |
Ohio15 | A provider who does not wish to comply with a patient’s declaration must notify the patient and any proxy and document the notification. The provider may not interfere with the patient’s transfer to another provider who is willing to follow the patient’s declaration. Providers may subject a patient to treatment contrary to a declaration only if:
|
Oklahoma16 | Physicians and psychologists must follow as closely as possible the terms of a patient’s declaration. A provider who cannot comply with the terms of the patient’s declaration must make arrangements to transfer the patient and the appropriate medical records without delay to another physician or psychologist |
Pennsylvania17 | If a provider cannot in good conscience comply with a patient’s declaration because the instructions are contrary to accepted clinical practice and medical standards, the provider must make every reasonable effort to help transfer care to another provider who will comply with the declaration. While the transfer is pending, the provider must provide treatment in a way that is consistent with the declaration. If reasonable efforts to transfer fail, the patient may be discharged |
Utah18 | A physician must comply with a declaration to the fullest extent possible, consistent with reasonable medical practice, the availability of treatments requested, and applicable law. A physician may subject a patient to treatment contrary to wishes expressed in a declaration if:
|
Table 2
Excerpts from state laws on PAD-related liability
State | Liability or immunity |
---|---|
Oklahoma16 | A provider who transfers the patient without unreasonable delay to another provider or who makes a good faith attempt to do so may not be subject to criminal prosecution or civil liability. The provider may not be found to have committed an act of unprofessional conduct for refusal to comply with the terms of the declaration, and transfer under such circumstances shall not constitute abandonment. However, the failure of a provider to transfer in accordance with this subsection shall constitute professional misconduct |
Pennsylvania17 | A provider who acts in good faith and consistent with the statute may not be subject to criminal or civil liability, discipline for unprofessional conduct, or administrative sanctions. A provider may not be found to have committed an act of unprofessional conduct by the relevant state professional board because the provider refused to comply with:
|
PAD: psychiatric advance directive |
Related Resources
- National Resource Center on Psychiatric Advance Directives. www.nrc-pad.org.
- Duke University Program on Psychiatric Advance Directives. http://pad.duhs.duke.edu.
- Hung EK, McNiel DE, Binder RL. Covert medication in psychiatric emergencies: is it ever ethically permissible? J Am Acad Psychiatry Law. 2012;40(2):239-245.
Disclosure
The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
1. Eclavea RP, Martin LD. State-created right to refuse medication. 53 Am. Jur. 2d Mentally Impaired Persons § 111 (West 2012).
2. Aitken PV, Jr. Incorporating advance care planning into family practice. Am Fam Physician. 1999;59(3):605-614, 617–620.
3. Gallagher EM. Advance directives for psychiatric care: a theoretical and practical overview for legal professionals. Psychol Public Policy Law. 1998;4(3):746-787.
4. DeWolf Bosek MS, Ring ME, Cady RF. Do psychiatric advance directives protect autonomy? JONAS Healthc Law Ethics Regul. 2008;10(1):17-24.
5. Patient Self Determination Act 42 USC § 1395cc 1396a (1994)
6. Swanson JW, McCrary SV, Swartz MS, et al. Superseding psychiatric advance directives: ethical and legal considerations. J Am Acad Psychiatry Law. 2006;34(3):385-394.
7. Swanson J, Swartz M, Ferron J, et al. Psychiatric advance directives among public mental health consumers in five U.S. cities: prevalence, demand, and correlates. J Am Acad Psychiatry Law. 2006;34(1):43-57.
8. National Alliance on Mental Illness. Psychiatric advance directives. http://www.nami.org/Template.cfm?Section=Issue_Spotlights&Template=/TaggedPage/TaggedPageDisplay.cfm&TPLID=5&ContentID=8217. Accessed July 11, 2012.
9. Mental Health America. My plan, my life: my psychiatric advance directive. http://www.myplanmylife.com. Accessed July 23, 2012.
10. Hargrave v Vermont 340 F3d 27 (2d Cir Vt 2003).
11. Americans with Disabilities Act, 42 USCA § 12132
12. Appelbaum PS. Law & psychiatry: psychiatric advance directives and the treatment of committed patients. Psychiatr Serv. 2004;55(7):751-752, 763.
13. Appelbaum PS. Commentary: psychiatric advance directives at a crossroads—when can PADs be overridden? J Am Acad Psychiatry Law. 2006;34(3):395-397.
14. Ky Rev State § 202A.426 (Michie 2012).
15. Ohio Rev Code § 2135.07 (Page 2012).
16. 43A Okla. St.§ 11-110 (Lexis 2012).
17. 20 Pa. Cons. Stat. §5804.
18. Utah Code Ann. § 62A-15-1003 (Lexis, 2012).
19. Swanson JW, Van McCrary S, Swartz MS, et al. Overriding psychiatric advance directives: factors associated with psychiatrists’ decisions to preempt patients’ advance refusal of hospitalization and medication. Law Hum Behav. 2007;31(1):77-90.
Discuss this article at www.facebook.com/CurrentPsychiatry
Dear Dr. Mossman:
My patient stopped antipsychotic medication, experienced a recurrence of paranoid schizophrenia, and now is involuntarily hospitalized. During her admission assessment, she said she had a “psychiatric advance directive.” I obtained the document, which says she refuses psychopharmacologic treatment under any circumstances. Without medication, she might take years to recover. How should I proceed?
Submitted by “Dr. Y”
Most psychiatrists who regularly practice hospital-based care know their state’s legal procedures for forcing psychotic, civilly committed patients to take medication to relieve their acute symptoms. In most jurisdictions, courts will order medication over a patient’s objection after finding that the patient lacks competence to refuse antipsychotic therapy and that the proposed treatment is in the patient’s best interest.1
But if a patient has a psychiatric advance directive (PAD) that opposes psychotropic medication, things may become complicated. To decide what to do if a patient’s PAD precludes administering a treatment you think is necessary, you should understand:
- what PADs do
- what courts have said about PADs
- what your state’s laws say about PADs
- where and when to seek legal advice.
What are advance directives?
An advance directive (or “declaration”) for health care (ADHC) is a legal document executed by a competent individual that states preferences regarding medical treatment should that individual become incapable of making or expressing decisions.2-4 An ADHC may be a “living will” that lays out instructions for specific health care situations or a “durable power of attorney” (DPOA) that designates a proxy decision maker, or it may include elements of both. In 1990, the U.S. Congress passed the Patient Self-Determination Act,5 which required health care institutions that receive Medicare or Medicaid to ask patients whether they have ADHCs and to give patients information about state laws governing ADHCs.
Modeled after medical advance directives, PADs let competent individuals declare their wishes should they need psychiatric treatment during a period of decision-making incapacity.3,4 At least 25 states have advance directive statutes specific to psychiatry.6 Depending on the state, PADs may allow individuals to assert their preferences regarding psychotropic medication, electroconvulsive therapy (ECT), alternatives to hospitalization, location and length of voluntary hospitalization, the treating psychiatrist, seclusion and restraint, emergency medications, and visitors.
Prevalence and praise
The prevalence of PADs is unknown. A 2006 survey of 1,011 psychiatric outpatients in California, Florida, Illinois, Massachusetts, and North Carolina by Swanson et al7 found only 4% to 13% of patients previously executed a PAD. However, most participants said that if given the opportunity and assistance, they would create a PAD.7
Psychiatric advocacy groups have lauded the development of PADs. For example, the National Alliance on Mental Illness’ position is that “PADs should be considered as a way to empower consumers to take a more active role in their treatment, and as a way to avoid conflicts over treatment and medication issues.”8 Proponents suggest that PADs:
- promote autonomy
- foster communication between patients and treatment providers
- increase compliance with medication
- reduce involuntary treatment and judicial involvement.4,8
Mental Health America launched My Plan, My Life: My Psychiatric Advance Directive in September 2011 to increase public awareness of the availability of PADs.9 Therefore, it is safe to assume that most psychiatrists will encounter patients with PADs.
What if a PAD blocks treatment?
What happens when an adult such as Dr. Y’s patient has a PAD that precludes effective treatment? A similar situation led to Hargrave v Vermont.10
Nancy Hargrave, a Vermont woman with schizophrenia and a history of psychiatric hospitalizations, executed a DPOA—Vermont does not have a separate statute for PADs—in which she explicitly refused “any and all anti-psychotic, neuroleptic, psychotropic, or psychoactive medications,” and ECT.10
In anticipation of situations like this, Vermont’s legislature passed Act 114, a 1998 state law that required caregivers to abide by the DPOAs of civilly committed individuals and mentally ill prisoners for 45 days.10 After this time, a court may override the advance directive and allow involuntary medication administration if a patient “ha[d] not experienced a significant clinical improvement in his or her mental state, and remain[ed] incompetent.”10
In 1999, Hargrave sued the state of Vermont and other parties in federal court, alleging that Act 114 constituted discrimination under Title II of the Americans with Disabilities Act11 because Act 114 excluded her from participating in the “services, programs, or activities of a public entity,” namely, the use of her DPOA under Vermont state law.10 The federal district court sided with Hargrave, concluding that “Act 114 was facially discriminatory against mentally disabled individuals.” One year later, the U.S. Court of Appeals for the Second Circuit affirmed the district court’s ruling.
Surprisingly, no other court has adjudicated this issue. However, in Second Circuit states—Vermont, New York, and Connecticut—DPOAs of mentally ill patients cannot be abrogated. This is an unsettling notion for many psychiatrists, because, as Paul Appelbaum, MD, explains, “Advance directives may now constitute an ironclad bulwark against future involuntary treatment with medication—except in emergencies—even for incompetent, committed patients and even when the alternative is long-term institutional care.”12 Other scholars have pointed out that giving physicians an avenue to override or disregard patients’ directives would negate their intended purpose, which is to have one’s competently expressed wishes followed when one’s decision-making capacity is compromised.6,13
Doctors’ duties
How you should respond to an involuntary patient’s PAD depends on which state you practice in. A physician’s obligation to comply with a patient’s PAD depends on state law, and most states with PAD laws provide some latitude or options if physicians believe they should not comply with a patient’s wishes.6,13Table 114-18 cites examples of statutory language regarding a physician’s duty to comply with a PAD.
A survey of 164 psychiatrists in North Carolina provides some insight into psychiatrists’ perceptions of PADs.19 After reading a hypothetical scenario about a mentally ill individual whose PAD expressed refusal of hospitalization or treatment with antipsychotics, 47% of the psychiatrists chose to override the PAD. The authors found that “PAD override was more likely among psychiatrists who worked in hospital emergency departments; those who were concerned about patients’ violence risk and lack of insight; and those who were legally defensive.”
In addition to addressing conflicts between patients’ PADs and doctors’ views about proper treatment, some state laws also contain clauses that spell out the limits of physician liability in cases of physician compliance or noncompliance with PADs. Excerpts from 2 such laws appear in Table 2.16-17
Table 1
Examples of state laws on compliance with psychiatric advance directives
State | Provider compliance |
---|---|
Kentucky14 | Providers must provide mental health treatment that complies with the instructions in an advance directive to the fullest extent possible when the instructions are within standards for mental and physical health care and permitted by state and federal law. Providers may override expressed refusals of treatment only if a court order contradicts the advance directive or an emergency endangers a patient’s life or poses a serious risk to physical health |
Ohio15 | A provider who does not wish to comply with a patient’s declaration must notify the patient and any proxy and document the notification. The provider may not interfere with the patient’s transfer to another provider who is willing to follow the patient’s declaration. Providers may subject a patient to treatment contrary to a declaration only if:
|
Oklahoma16 | Physicians and psychologists must follow as closely as possible the terms of a patient’s declaration. A provider who cannot comply with the terms of the patient’s declaration must make arrangements to transfer the patient and the appropriate medical records without delay to another physician or psychologist |
Pennsylvania17 | If a provider cannot in good conscience comply with a patient’s declaration because the instructions are contrary to accepted clinical practice and medical standards, the provider must make every reasonable effort to help transfer care to another provider who will comply with the declaration. While the transfer is pending, the provider must provide treatment in a way that is consistent with the declaration. If reasonable efforts to transfer fail, the patient may be discharged |
Utah18 | A physician must comply with a declaration to the fullest extent possible, consistent with reasonable medical practice, the availability of treatments requested, and applicable law. A physician may subject a patient to treatment contrary to wishes expressed in a declaration if:
|
Table 2
Excerpts from state laws on PAD-related liability
State | Liability or immunity |
---|---|
Oklahoma16 | A provider who transfers the patient without unreasonable delay to another provider or who makes a good faith attempt to do so may not be subject to criminal prosecution or civil liability. The provider may not be found to have committed an act of unprofessional conduct for refusal to comply with the terms of the declaration, and transfer under such circumstances shall not constitute abandonment. However, the failure of a provider to transfer in accordance with this subsection shall constitute professional misconduct |
Pennsylvania17 | A provider who acts in good faith and consistent with the statute may not be subject to criminal or civil liability, discipline for unprofessional conduct, or administrative sanctions. A provider may not be found to have committed an act of unprofessional conduct by the relevant state professional board because the provider refused to comply with:
|
PAD: psychiatric advance directive |
Related Resources
- National Resource Center on Psychiatric Advance Directives. www.nrc-pad.org.
- Duke University Program on Psychiatric Advance Directives. http://pad.duhs.duke.edu.
- Hung EK, McNiel DE, Binder RL. Covert medication in psychiatric emergencies: is it ever ethically permissible? J Am Acad Psychiatry Law. 2012;40(2):239-245.
Disclosure
The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
Discuss this article at www.facebook.com/CurrentPsychiatry
Dear Dr. Mossman:
My patient stopped antipsychotic medication, experienced a recurrence of paranoid schizophrenia, and now is involuntarily hospitalized. During her admission assessment, she said she had a “psychiatric advance directive.” I obtained the document, which says she refuses psychopharmacologic treatment under any circumstances. Without medication, she might take years to recover. How should I proceed?
Submitted by “Dr. Y”
Most psychiatrists who regularly practice hospital-based care know their state’s legal procedures for forcing psychotic, civilly committed patients to take medication to relieve their acute symptoms. In most jurisdictions, courts will order medication over a patient’s objection after finding that the patient lacks competence to refuse antipsychotic therapy and that the proposed treatment is in the patient’s best interest.1
But if a patient has a psychiatric advance directive (PAD) that opposes psychotropic medication, things may become complicated. To decide what to do if a patient’s PAD precludes administering a treatment you think is necessary, you should understand:
- what PADs do
- what courts have said about PADs
- what your state’s laws say about PADs
- where and when to seek legal advice.
What are advance directives?
An advance directive (or “declaration”) for health care (ADHC) is a legal document executed by a competent individual that states preferences regarding medical treatment should that individual become incapable of making or expressing decisions.2-4 An ADHC may be a “living will” that lays out instructions for specific health care situations or a “durable power of attorney” (DPOA) that designates a proxy decision maker, or it may include elements of both. In 1990, the U.S. Congress passed the Patient Self-Determination Act,5 which required health care institutions that receive Medicare or Medicaid to ask patients whether they have ADHCs and to give patients information about state laws governing ADHCs.
Modeled after medical advance directives, PADs let competent individuals declare their wishes should they need psychiatric treatment during a period of decision-making incapacity.3,4 At least 25 states have advance directive statutes specific to psychiatry.6 Depending on the state, PADs may allow individuals to assert their preferences regarding psychotropic medication, electroconvulsive therapy (ECT), alternatives to hospitalization, location and length of voluntary hospitalization, the treating psychiatrist, seclusion and restraint, emergency medications, and visitors.
Prevalence and praise
The prevalence of PADs is unknown. A 2006 survey of 1,011 psychiatric outpatients in California, Florida, Illinois, Massachusetts, and North Carolina by Swanson et al7 found only 4% to 13% of patients previously executed a PAD. However, most participants said that if given the opportunity and assistance, they would create a PAD.7
Psychiatric advocacy groups have lauded the development of PADs. For example, the National Alliance on Mental Illness’ position is that “PADs should be considered as a way to empower consumers to take a more active role in their treatment, and as a way to avoid conflicts over treatment and medication issues.”8 Proponents suggest that PADs:
- promote autonomy
- foster communication between patients and treatment providers
- increase compliance with medication
- reduce involuntary treatment and judicial involvement.4,8
Mental Health America launched My Plan, My Life: My Psychiatric Advance Directive in September 2011 to increase public awareness of the availability of PADs.9 Therefore, it is safe to assume that most psychiatrists will encounter patients with PADs.
What if a PAD blocks treatment?
What happens when an adult such as Dr. Y’s patient has a PAD that precludes effective treatment? A similar situation led to Hargrave v Vermont.10
Nancy Hargrave, a Vermont woman with schizophrenia and a history of psychiatric hospitalizations, executed a DPOA—Vermont does not have a separate statute for PADs—in which she explicitly refused “any and all anti-psychotic, neuroleptic, psychotropic, or psychoactive medications,” and ECT.10
In anticipation of situations like this, Vermont’s legislature passed Act 114, a 1998 state law that required caregivers to abide by the DPOAs of civilly committed individuals and mentally ill prisoners for 45 days.10 After this time, a court may override the advance directive and allow involuntary medication administration if a patient “ha[d] not experienced a significant clinical improvement in his or her mental state, and remain[ed] incompetent.”10
In 1999, Hargrave sued the state of Vermont and other parties in federal court, alleging that Act 114 constituted discrimination under Title II of the Americans with Disabilities Act11 because Act 114 excluded her from participating in the “services, programs, or activities of a public entity,” namely, the use of her DPOA under Vermont state law.10 The federal district court sided with Hargrave, concluding that “Act 114 was facially discriminatory against mentally disabled individuals.” One year later, the U.S. Court of Appeals for the Second Circuit affirmed the district court’s ruling.
Surprisingly, no other court has adjudicated this issue. However, in Second Circuit states—Vermont, New York, and Connecticut—DPOAs of mentally ill patients cannot be abrogated. This is an unsettling notion for many psychiatrists, because, as Paul Appelbaum, MD, explains, “Advance directives may now constitute an ironclad bulwark against future involuntary treatment with medication—except in emergencies—even for incompetent, committed patients and even when the alternative is long-term institutional care.”12 Other scholars have pointed out that giving physicians an avenue to override or disregard patients’ directives would negate their intended purpose, which is to have one’s competently expressed wishes followed when one’s decision-making capacity is compromised.6,13
Doctors’ duties
How you should respond to an involuntary patient’s PAD depends on which state you practice in. A physician’s obligation to comply with a patient’s PAD depends on state law, and most states with PAD laws provide some latitude or options if physicians believe they should not comply with a patient’s wishes.6,13Table 114-18 cites examples of statutory language regarding a physician’s duty to comply with a PAD.
A survey of 164 psychiatrists in North Carolina provides some insight into psychiatrists’ perceptions of PADs.19 After reading a hypothetical scenario about a mentally ill individual whose PAD expressed refusal of hospitalization or treatment with antipsychotics, 47% of the psychiatrists chose to override the PAD. The authors found that “PAD override was more likely among psychiatrists who worked in hospital emergency departments; those who were concerned about patients’ violence risk and lack of insight; and those who were legally defensive.”
In addition to addressing conflicts between patients’ PADs and doctors’ views about proper treatment, some state laws also contain clauses that spell out the limits of physician liability in cases of physician compliance or noncompliance with PADs. Excerpts from 2 such laws appear in Table 2.16-17
Table 1
Examples of state laws on compliance with psychiatric advance directives
State | Provider compliance |
---|---|
Kentucky14 | Providers must provide mental health treatment that complies with the instructions in an advance directive to the fullest extent possible when the instructions are within standards for mental and physical health care and permitted by state and federal law. Providers may override expressed refusals of treatment only if a court order contradicts the advance directive or an emergency endangers a patient’s life or poses a serious risk to physical health |
Ohio15 | A provider who does not wish to comply with a patient’s declaration must notify the patient and any proxy and document the notification. The provider may not interfere with the patient’s transfer to another provider who is willing to follow the patient’s declaration. Providers may subject a patient to treatment contrary to a declaration only if:
|
Oklahoma16 | Physicians and psychologists must follow as closely as possible the terms of a patient’s declaration. A provider who cannot comply with the terms of the patient’s declaration must make arrangements to transfer the patient and the appropriate medical records without delay to another physician or psychologist |
Pennsylvania17 | If a provider cannot in good conscience comply with a patient’s declaration because the instructions are contrary to accepted clinical practice and medical standards, the provider must make every reasonable effort to help transfer care to another provider who will comply with the declaration. While the transfer is pending, the provider must provide treatment in a way that is consistent with the declaration. If reasonable efforts to transfer fail, the patient may be discharged |
Utah18 | A physician must comply with a declaration to the fullest extent possible, consistent with reasonable medical practice, the availability of treatments requested, and applicable law. A physician may subject a patient to treatment contrary to wishes expressed in a declaration if:
|
Table 2
Excerpts from state laws on PAD-related liability
State | Liability or immunity |
---|---|
Oklahoma16 | A provider who transfers the patient without unreasonable delay to another provider or who makes a good faith attempt to do so may not be subject to criminal prosecution or civil liability. The provider may not be found to have committed an act of unprofessional conduct for refusal to comply with the terms of the declaration, and transfer under such circumstances shall not constitute abandonment. However, the failure of a provider to transfer in accordance with this subsection shall constitute professional misconduct |
Pennsylvania17 | A provider who acts in good faith and consistent with the statute may not be subject to criminal or civil liability, discipline for unprofessional conduct, or administrative sanctions. A provider may not be found to have committed an act of unprofessional conduct by the relevant state professional board because the provider refused to comply with:
|
PAD: psychiatric advance directive |
Related Resources
- National Resource Center on Psychiatric Advance Directives. www.nrc-pad.org.
- Duke University Program on Psychiatric Advance Directives. http://pad.duhs.duke.edu.
- Hung EK, McNiel DE, Binder RL. Covert medication in psychiatric emergencies: is it ever ethically permissible? J Am Acad Psychiatry Law. 2012;40(2):239-245.
Disclosure
The authors report no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
1. Eclavea RP, Martin LD. State-created right to refuse medication. 53 Am. Jur. 2d Mentally Impaired Persons § 111 (West 2012).
2. Aitken PV, Jr. Incorporating advance care planning into family practice. Am Fam Physician. 1999;59(3):605-614, 617–620.
3. Gallagher EM. Advance directives for psychiatric care: a theoretical and practical overview for legal professionals. Psychol Public Policy Law. 1998;4(3):746-787.
4. DeWolf Bosek MS, Ring ME, Cady RF. Do psychiatric advance directives protect autonomy? JONAS Healthc Law Ethics Regul. 2008;10(1):17-24.
5. Patient Self Determination Act 42 USC § 1395cc 1396a (1994)
6. Swanson JW, McCrary SV, Swartz MS, et al. Superseding psychiatric advance directives: ethical and legal considerations. J Am Acad Psychiatry Law. 2006;34(3):385-394.
7. Swanson J, Swartz M, Ferron J, et al. Psychiatric advance directives among public mental health consumers in five U.S. cities: prevalence, demand, and correlates. J Am Acad Psychiatry Law. 2006;34(1):43-57.
8. National Alliance on Mental Illness. Psychiatric advance directives. http://www.nami.org/Template.cfm?Section=Issue_Spotlights&Template=/TaggedPage/TaggedPageDisplay.cfm&TPLID=5&ContentID=8217. Accessed July 11, 2012.
9. Mental Health America. My plan, my life: my psychiatric advance directive. http://www.myplanmylife.com. Accessed July 23, 2012.
10. Hargrave v Vermont 340 F3d 27 (2d Cir Vt 2003).
11. Americans with Disabilities Act, 42 USCA § 12132
12. Appelbaum PS. Law & psychiatry: psychiatric advance directives and the treatment of committed patients. Psychiatr Serv. 2004;55(7):751-752, 763.
13. Appelbaum PS. Commentary: psychiatric advance directives at a crossroads—when can PADs be overridden? J Am Acad Psychiatry Law. 2006;34(3):395-397.
14. Ky Rev State § 202A.426 (Michie 2012).
15. Ohio Rev Code § 2135.07 (Page 2012).
16. 43A Okla. St.§ 11-110 (Lexis 2012).
17. 20 Pa. Cons. Stat. §5804.
18. Utah Code Ann. § 62A-15-1003 (Lexis, 2012).
19. Swanson JW, Van McCrary S, Swartz MS, et al. Overriding psychiatric advance directives: factors associated with psychiatrists’ decisions to preempt patients’ advance refusal of hospitalization and medication. Law Hum Behav. 2007;31(1):77-90.
1. Eclavea RP, Martin LD. State-created right to refuse medication. 53 Am. Jur. 2d Mentally Impaired Persons § 111 (West 2012).
2. Aitken PV, Jr. Incorporating advance care planning into family practice. Am Fam Physician. 1999;59(3):605-614, 617–620.
3. Gallagher EM. Advance directives for psychiatric care: a theoretical and practical overview for legal professionals. Psychol Public Policy Law. 1998;4(3):746-787.
4. DeWolf Bosek MS, Ring ME, Cady RF. Do psychiatric advance directives protect autonomy? JONAS Healthc Law Ethics Regul. 2008;10(1):17-24.
5. Patient Self Determination Act 42 USC § 1395cc 1396a (1994)
6. Swanson JW, McCrary SV, Swartz MS, et al. Superseding psychiatric advance directives: ethical and legal considerations. J Am Acad Psychiatry Law. 2006;34(3):385-394.
7. Swanson J, Swartz M, Ferron J, et al. Psychiatric advance directives among public mental health consumers in five U.S. cities: prevalence, demand, and correlates. J Am Acad Psychiatry Law. 2006;34(1):43-57.
8. National Alliance on Mental Illness. Psychiatric advance directives. http://www.nami.org/Template.cfm?Section=Issue_Spotlights&Template=/TaggedPage/TaggedPageDisplay.cfm&TPLID=5&ContentID=8217. Accessed July 11, 2012.
9. Mental Health America. My plan, my life: my psychiatric advance directive. http://www.myplanmylife.com. Accessed July 23, 2012.
10. Hargrave v Vermont 340 F3d 27 (2d Cir Vt 2003).
11. Americans with Disabilities Act, 42 USCA § 12132
12. Appelbaum PS. Law & psychiatry: psychiatric advance directives and the treatment of committed patients. Psychiatr Serv. 2004;55(7):751-752, 763.
13. Appelbaum PS. Commentary: psychiatric advance directives at a crossroads—when can PADs be overridden? J Am Acad Psychiatry Law. 2006;34(3):395-397.
14. Ky Rev State § 202A.426 (Michie 2012).
15. Ohio Rev Code § 2135.07 (Page 2012).
16. 43A Okla. St.§ 11-110 (Lexis 2012).
17. 20 Pa. Cons. Stat. §5804.
18. Utah Code Ann. § 62A-15-1003 (Lexis, 2012).
19. Swanson JW, Van McCrary S, Swartz MS, et al. Overriding psychiatric advance directives: factors associated with psychiatrists’ decisions to preempt patients’ advance refusal of hospitalization and medication. Law Hum Behav. 2007;31(1):77-90.